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Abstract
This introductory statement draws together key findings and implications of my published 
work on nurse prescribing in England. A review of literature available in 2006 (when I 
began this work), illustrates that although advances had been made in the evaluation of 
community nurse prescribing, little research had been undertaken on the more recently 
introduced nurse independent and nurse supplementary prescribing. As these latter 
forms of prescribing were open to nurses from a range of clinical backgrounds and work 
settings, further research was required to evaluate their impact and to inform service 
development. Furthermore, there had been no evaluation of the extension of nurse 
independent prescribing rights in 2006. The publications contribute to understanding the 
impact of nurse prescribing and the factors that influence its uptake, use and 
development in the areas of pain, dermatology and diabetes. Publications result from my 
contribution to five projects using a range of methods, although seven of the eight 
publications report on qualitative interview data from key stakeholders. After outlining 
key issues in the three treatment areas, the discussion focuses on the contribution that 
these publications make to knowledge and understanding about how nurse prescribing 
impacts on patient-care, inter-professional relationships and the role o f the nurse. 
Factors influencing the implementation and use of nurse prescribing in the three 
treatment areas are detailed. Key methodological issues are presented in relation to 
interview study, questionnaire survey and the case study approach. Theoretical 
implications are explored using the principles of realistic evaluation to generate 
theoretical propositions based on the cumulative research evidence provided. From this, 
a framework is presented that identifies factors for consideration for the successful 
implementation of non-medical prescribing. It is anticipated that this framework, once 
tested and refined through future research, will provide guidance to commissioners and 
managers wishing to initiate or extend non-medical prescribing.
Key words
Nurse prescribing, advancing nurse roles, pain, diabetes, service development
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INTRODUCTORY STATEMENT
1. O verv iew
This introductory statement draws together the key findings and implications of my 
published work on nurse prescribing. The focus of these publications is the evaluation of 
nurse independent and supplementary prescribing in the areas of pain, dermatology and 
diabetes. The statement begins in section two with a review of the research literature on 
nurse prescribing that was available at the time that I began this work in 2006. The 
review identifies a lack of research on this topic and key gaps in knowledge at that time. 
Following the review, key issues and background information about the development of 
the research projects and publications that contribute to this thesis in the treatment 
areas of pain, dermatology and diabetes are set out in section three. Section four is a 
discussion of the contribution that the publications make to knowledge in the field of 
study and the implications for practice. I discuss the investigative approach and 
methodologies used, theoretical considerations and implications for future work. This is 
followed by a description of how the work has been disseminated in the field of study 
and evidence of its impact. Recommendations for future research are summarised at the 
end of the discussion. Concluding remarks are made in section five.
2. L iterature review
2.1 Introduction
There has been a gradual development of nurse prescribing in the United Kingdom (UK) 
since its inception in 1994, accompanied by a string of related legislative change. The
12
result is a somewhat confusing picture with different prescribing rights having been 
granted to different groups of nurses and other health professionals at different times. 
Following a pilot of nurse prescribing for Community Nurses (at the time District Nurses 
and Health Visitors) in 1994, nurse prescribing for community nurses was fully 
introduced in 1998 (Medicines and Health Care Products Regulatory Agency (MHRA) 
2005). These nurses were restricted to prescribing for patients in the community from a 
formulary of a limited number of items (dressings, appliances and some medicines). This 
formulary is currently known as the ‘Nurse Prescribers Formulary for Community 
Practitioners’ and nurses using this qualification today must only prescribe items that are 
listed in this formulary.
Following the 2001 Health and Social Care Act, rights were extended to all registered 
nurses and midwives to qualify as an Extended Formulary Nurse Prescriber (EFNP) and 
to prescribe from the Nurse Prescribers Extended Formulary (NPEF). The formulary 
restricted prescribing to around 120 items for specific conditions (Courtenay & Griffiths
2004). At this point, a distinction was made between independent and supplementary 
prescribing. Community nurse prescribers and EFNPs are independent prescribers, 
responsible for assessment and diagnosis (which may include initial diagnosis), making 
decisions about clinical management, and prescribing. Independent prescribing is 
defined as:
Prescribing by a practitioner (e.g. doctor, dentist, nurse and pharmacist) 
responsible and accountable for the assessment of patients with undiagnosed or 
diagnosed conditions and for decisions about the clinical management required, 
including prescribing.’ (Department of Health (DH) 2006: 2).
Supplementary prescribing was introduced in 2003 for nurses and pharmacist. With 
Nurse Supplementary Prescribing (NSP), a doctor is responsible for the initial diagnosis
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of the patient and the nurse is responsible for continuing care, which may include 
prescribing or altering prescriptions within the limits set out by a Clinical Management 
Plan (CMP). Supplementary prescribing is defined as:
‘A  voluntary partnership between an independent prescriber (a doctor or dentist) 
and a supplementary prescriber to implement an agreed patient-specific Clinical 
Management Plan with the patient’s agreement’. (DH 2003: 6)
A landmark change to prescribing rights for EFNPs occurred following The Medicines 
and Human Use (Prescribing) (Miscellaneous Amendments) Order 2006, which paved 
the way for EFNPs, now called Nurse Independent Prescribers (NIPs) to prescribe any 
licensed1 medicine, including some Controlled Drugs2, for any medical condition within 
their clinical competence (DH 2006). This important change meant that NIPs were no 
longer restricted to prescribing from a limited formulary but could prescribe any medicine 
listed in the British National Formulary (BNF) within their area of competence, including 
some controlled drugs.
The development of nurse prescribing was facilitated by a health policy environment 
which actively promoted the advancement of nurse roles. The introduction of NIP/NSP 
coincided with the government led modernisation agenda for the NHS (DH 2000). The 
document ‘Making a difference’ (DH 1999) set out the strategic intentions for 
modernising nursing roles, promising to lift constraints that limited innovation by nurses, 
mid wives and health visitors. This set the way for extending nursing roles in order to 
enable better use of existing knowledge and skills, including making it easier for nurses 
to prescribe medication. One of the anticipated benefits of nurse prescribing was the
1 A licensed medicine is a product with a valid marketing authorisation or license in the UK. In December 
2009, legislation was amended to allow nurse and midwife independent prescribers to prescribe unlicensed 
medicines (The Medicines for Human Use (Miscellaneous Amendments) (No.2), Regulations. SI 2009 
3063)
2 Controlled Drugs are substances listed in The Misuse o f Drugs Regulations 2001
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potential to make better use of existing skills and increase flexible working within teams 
(DH 2006). Faced with an ageing population and increasing incidence of long-term 
conditions, the NHS Plan paved the way for more flexible and innovative ways of 
working in the NHS in order to deliver healthcare improvements (DH 2000). At the same 
time, the already stretched healthcare workforce was challenged further by the 
introduction of the European Working Time Directives, resulting in a reduction in Junior 
Doctors working hours (DH 2003). Non-medical prescribing (NMP) was therefore 
introduced primarily as a means to increase service efficiency and improve access to 
medicine by making better use of the skills of health professionals (DH 2006). However, 
the introduction of NMP was not without criticism (Cressey 2006). Concerns over the 
safety of nurse prescribing were raised by members of the British Medical Association 
(Avery & Pringle 2005). In addition, the logic of extending the role of nurses in order to 
compensate for shortages in the medical workforce has received criticism in the light of 
shortcomings in the numbers of appropriately qualified nurses in the UK (Stubbings & 
Scott 2004). There was therefore a need to evaluate the impact of nurse prescribing on 
patient care, service delivery and the changing roles of health professionals.
I began my research on nurse prescribing in 2005/2006 at the time when the new 
legislation was being implemented. The purpose of this review is to describe 
retrospectively what literature was available on nurse prescribing in the period prior to 
2006. This will give an overview of the background to my work and identify the main 
knowledge gaps. As the focus of my research has been the evaluation of NIP and NSP 
prescribing, the review will concentrate on research pertaining to these forms of 
prescribing, however, I will first provide a background description of research relating to 
community nurse prescribing.
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2.2 Background
Early evaluations of nurse prescribing by community nurses were generally positive, as 
described in a literature review by Latter and Courtenay (2004). The views of community 
nurses, either in training or qualified as nurse prescribers, have been explored in studies 
using questionnaire survey (Otway 2001, Otway 2002, Rodden 2001, While & Biggs
2004) and interviews or focus groups (Humphries & Green 2000, Lewis-Evans & Jester 
2004, Luker et al. 1998a). Reported benefits included efficiency savings, increased job 
satisfaction and the ability to provide complete episodes of care (Luker & McHugh 2002, 
Lewis-Evans & Jester 2004). Nurses believed they were good at giving information to 
patients about medicines and that prescribing reduced nurses dependence on doctors 
and improved flexible working within teams (Luker & McHugh 2002, Rodden 2001). Two 
studies included interviews with patients who had been prescribed medicines by 
community nurses (Brooks et al. 2001a, b, Luker et al. 1997, Luker et al. 1998a). The 
results of the two studies were similar in that the majority of patients were happy to be 
prescribed by a nurse and welcomed the improved efficiency and access to medicines. 
Patients reported that nurses were more approachable and understanding, provided 
more information, and were more knowledgeable in some treatment areas than doctors. 
However, the need for continued involvement of a doctor was emphasised as 
participants said they would want to consult with a doctor for conditions that they 
considered serious.
Although early evaluations indicated that nurse prescribing was largely successful, 
concerns were raised that around a quarter of community nurse prescribers were not 
using their qualification to prescribe (Luker & McHugh 2002). Significant differences 
between prescribing rates of District Nurses (DNs) and Health Visitors (HV) were 
reported, with DNs prescribing more frequently than HVs (Luker & McHugh 2002, Otway
16
2001, Rodden 2001, While & Biggs 2004). Infrequent prescribing was reported to reduce 
the confidence of nurses in this role (Luker et al. 1998a), whereas peer support from 
other nurse prescribers was thought to increase prescribing activity (Otway 2001). 
Another common barrier reported was that the nurse prescribing formulary limited the 
extent that nurses could prescribe (Lewis-Evans & Jester 2004, Luker & McHugh 2002, 
Otway 2002). Delays in receiving prescribing pads (Luker & McHugh 2002), and access 
to patient notes or computerised technology to aid prescribing were also reported 
(Humphries & Green 2000, Lewis-Evans & Jester 2004, Otway 2002, While & Biggs
2004). In addition, some nurses felt inadequately trained in areas such as pharmacology 
(Lewis-Evans & Jester 2004, Luker et al. 1998a, Otway 2002).
The adequacy of nurse education for preparing nurses as prescribers was the subject of 
a narrative review of literature in the period 1994-2003 (Banning 2004). A  lack of 
literature evaluating nurses’ clinical competence to prescribe, including clinical decision­
making and nurses’ self-assessed competence to prescribe, was identified. Pre­
registration nurse education was argued to be inadequate to prepare nurses for the 
prescribing role. The evidence used to back this argument was, however, based upon 
one small study using patient vignettes to assess confidence and knowledge levels of 
nurse prescribers (Sodha et al. 2002). Indications were that lack of training in applied 
pharmacology and therapeutics may adversely affect nurses’ ability to manage 
medicines and communicate information to patients. Banning (2004) reported that 
changes to the nurse prescribing course were subsequently made to address these 
shortcomings, but warned that deficits in the scientific preparation of nurses in applied 
pharmacology and therapeutics could continue to prove problematic for EFNPs and 
NSPs unless shortfalls in the training programme were remedied.
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The need for ongoing support in terms of peer support, clinical supervision and access 
to Continued Professional Development (CRD) was consistently reported in this early 
work (Humphries & Green 2000, Lewis-Evans & Jester 2004, Luker & McHugh 2002, 
Otway 2001, 2002, While & Biggs 2004). This was considered particularly important if 
nurses scope of prescribing was to be extended to include new medicines (Humphries & 
Green 2000, Luker & McHugh 2002, Otway 2002). Being part of a team and having 
access to peer support was found to be important for supporting development of 
prescribing practice and confidence (Otway 2001, 2002). While nurses used a range of 
means of support, the level of formal support, such as mentoring or supervision, was 
variable (Otway 2001 & 2002, Luker & McHugh 2002, While & Biggs 2004).
While research on community nurse prescribing may provide some indication of the kind 
of issues to be faced by NIP/NSPs, there are also important differences. The extension 
of nurse prescribing to all nurse groups meant that there was likely to be a proliferation 
in the kinds of setting and practice areas in which nurses prescribed, including 
secondary care settings. The implications of these changes were unknown. Emerging 
issues for extended independent prescribing identified by Latter and Courtenay (2004) 
were potential role conflict and inconsistency in the prescribing training program. A 
number of studies were undertaken prior to the implementation of NIP/NSP to gauge the 
views of stakeholders on the appropriateness of this development and ascertain training 
needs. The majority of mental health nurses were in favour of nurse prescribing in their 
area of practice, (Hay et al. 2004, Hemingway 2004, Nolan et al. 2001), although there 
were concerns about its impact on the nursing role and team dynamics and that 
additional training would be required (Nolan et al. 2001). Hay et al. (2004) who 
conducted focus groups with a range of health professionals within one health trust, 
reported general support for NSP but confusion over how it would work and the potential
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impact on team work. The majority o f specialist children’s nurses, ward sisters and 
practice educators interviewed in an acute trust were in favour of nurse prescribing and 
anticipated benefits to service efficiency and quality of care (Gibson et al. 2003). 
Similarly, the majority o f family planning nurses surveyed (Tyler & Hicks 2001) were in 
favour of becoming nurse prescribers and a range of training needs were identified, 
including advanced clinical assessment and pharmacology.
In summary, while the initial wave of nurse prescribing had been positively evaluated, a 
number of barriers to its development were identified. The expansion of nurse 
prescribing beyond community nurses was generally anticipated to be a positive 
development so long as training needs were adequately addressed. As could be 
expected of research evaluating a new area of practice, most of the work conducted had 
used self-report methods collected through interviews, focus groups or questionnaire 
surveys with nurses or patients. Few studies had included other stakeholders, notably 
doctors. There were methodological weaknesses in that many studies involved small 
samples, often convenience samples, taken from single geographical locations (Latter & 
Courtenay 2004). It is notable, however, that two of the qualitative studies involved 
substantial numbers of participants (50 in the study by Brooks et al. 2001a and b, and 
over 100 in the study by Luker et al. 1997, 1998b), which helped to ensure that data 
saturation was achieved during analysis and therefore strengthening the findings.
2.3 Aim
The aim of this review was to describe and categorise research literature on nurse 
independent and nurse supplementary prescribing (then known as EFNPs) in the United 
Kingdom between 2002 and 2005.
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2.4 Literature review method
Much of the research on nurse prescribing has been explorative in nature and does not 
lend itself to traditional systematic review or meta-analysis techniques. A qualitative 
overview was the method chosen for this review as it enables the reviewer to 
meaningfully combine findings from studies that have used different methodologies 
(Dixon-Woods 2005).
2.4 .1 Literature searching strategy and inclusion criteria
The following electronic databases were searched: CINAHL, Medline, British Nursing 
Index (BNI), PSYCHINFO, Nursing and Medical Cross Search, Cochrane Library. The 
keywords used were: nurse AND prescribe*. In addition, a hand search was conducted 
using references to articles in the research papers retrieved. Due to the high volume of 
published material available, non-research publications and 'grey' literature such as 
personal accounts and policy documents were excluded. The search was conducted on 
17th November 2010.
Articles were included if they reported primary research on the uptake, use or impact of 
NSP/EFNP. Research undertaken prior to the initiation of NSP/EFNP, or which did not 
relate to either of these methods of prescribing, were not included. The inclusion criteria 
were:
• Primary research on NSP/EFNP published between January 2002 -  December
2005
• Peer reviewed journal articles or reports
• Written in the English language
• UK based studies
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2.4.2 Literature reviewing process
The literature underwent a critical review following a framework set out by Neill (2000: 
823 citing Sandelowski 1995), which enabled an accurate and unbiased reporting of the 
findings and identification of areas of agreement and disagreement between papers. The 
method involved a critical analysis of the methodology of each paper (including design, 
sample size, setting, participant details, procedures undertaken and data collection 
period) and a rigorous process of synthesising the findings. The analytic process used 
was that of thematic analysis (Braun & Clark 2006, Dixon-Woods 2005). This involved 
first reading the papers to develop a sense of the whole, collating findings, searching for 
key themes and categorising findings according to theme or sub-theme, then collating 
findings from each theme while retaining reference to the original source. These themes 
were then scrutinised for areas of consistency or incongruence between findings from 
different contexts until an overall interpretation of the findings was reached.
2.5 Review findings
2.5.1 Search results
A total of 107 abstracts were read, of which 7 met the inclusion criteria. Hand search 
identified one research report (Latter et al. 2005). A total of 8 publications were included 
in this review, the details of which are provided in Table 1.
Questionnaire surveys were used in four studies. Three studies reported data from 
interviews or focus groups. Two were small scale studies using prescribing data 
collected by one or two nurse prescribers and one study used mixed methods, including 
questionnaires, observation of practice and interviews.
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2.5.2 Methodological issues
Three studies used qualitative methods to explore views about nurse prescribing (Avery 
et al. 2004, Latter et al. 2005, Travers 2005); however, sample sizes were small and, 
with the exception of the study by Latter et al. (2005), were recruited from a single health 
trust. Two studies (Kimmer & Christian 2005, Pleasance & Brown sell 2004) were limited 
to reporting prescribing data related to one or two individuals. Of the four studies that 
included questionnaires (Bradley et al. 2005, Gray et al. 2005, Larsen 2004, Latter et al.
2005), three used a national sample (2 were total population and one a random sample) 
and one sampled student nurses at one university. This is an improvement on the 
research from the first phase of nurse prescribing that tended to use small samples in 
local geographical areas (Latter & Courtenay 2004). A  larger sample size increases the 
ability to generalise findings (Bryman 2004), however the questionnaires used were 
developed specifically for each project therefore limiting consistency and scope for 
comparison of findings across studies. Three articles (Table 1) did not specify the data 
collection period, making it difficult to determine the legislative context in which the work 
took place. Further issues are highlighted, where appropriate, within the review findings.
2.5.3 Key Themes
Thematic analysis resulted in the following key themes:
• Views of stakeholders: a) patients, b) doctors, c) other stakeholders
• Views of nurse prescribers
• Organisational perspectives
• Profile and prescribing patterns of nurse prescribers
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Table 1. Summary of studies included in literature review
Study Nurse
type
Method & data 
collection period
Sample size & 
setting
Avery et al. (2004). Doctors’ views on 
supervising nurse prescribers. Prescriber, 
5, 56-61.
Not
specified
Interviews 
(date not 
specified)
6 GPs and 6 
Hospital doctor 
supervisors of NPs
Bradley et al. (2005) Nurse prescribers: 
who are they and how do they perceive 
their role? Journal o f Advanced Nursing 
Sep, 51(5): 439-48.
NSP
and
EFNP
Questionnaire
survey
(2003-2004)
Four cohorts of 
nurses attending a 
prescribing course 
at one Midland 
University (n=91).
Gray et al. (2005) Mental health nurse 
supplementary prescribing: Mapping 
progress 1 year after implementation. 
Psychiatric Bulletin, 29 (8), 295-297.
NSP Questionnaire
survey
(March-June
2004)
45 of 83 Directors 
of nursing in NHS 
mental health 
trusts in England 
(54% response 
rate)
Kimmer & Christian (2005) A review of the 
usefulness and efficacy of independent 
nurse prescribing. Nurse Prescribing, 3 
(1): 39-42.
EFNP Self-report 
prescribing data 
over 6 weeks 
(Jan-March 2004)
2 nurses 
General practice
Larsen D. (2004) Issues affecting the 
growth of independent prescribing. 
Nursing Standard, 19 (2), 33-9.
EFNP Questionnaire
(2002)
192 of 307 nurse 
managers (62% 
response rate) 
A&E ( A 7 = 1 1 0 ) ,  MIU 
(n= 54), WIC (n= 
28)
Latter et al. (2005) An Evaluation of 
Extended Formulary Independent Nurse 
Prescribing. Final Report. DH and The 
University of Southampton.
EFNP Mixed methods: 
questionnaire 
(2003), 
observation, 
interviews (2004)
National survey 
246 (71% 
response rate) 
NPs, 10 case 
studies
Pleasance & Brownsell (2004) Improving 
communication between nurse prescribers 
and community pharmacists. Nurse 
Prescribing, Aug; 2 (4), 171-3
EFNP Action research, 
collection of 
prescribing data 
over 3 weeks 
(date not 
specified)
Walk-in Centre
Travers J. (2005) Professional issues for 
the future of nurse prescribing: a 
qualitative study. Nurse Prescribing, 3 (4), 
164-7.
EFNP Focus group and 
interviews 
(date not 
specified)
7 EFNP nurses 
working in primary 
care and 
community 
settings: 1 PCT
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2 . 5.4 Views o f stakeholders
a) Patients
One study examined the views of patients treated by a nurse prescriber within a case 
study approach (Latter et al. 2005). The study used multiple methods of data collection 
across 10 sites where nurses (r?=14) prescribed for patients. The sites were in general 
practice, community midwifery, community palliative care, secondary care 
ophthalmology and a walk-in-centre. Participants were purposively selected patients 
(n=208); 115 received a post-consultation questionnaire and 263 received a postal 
questionnaire (data collection period unspecified). Response rates were 97.4% (z?=112) 
for the post consultation questionnaire and 35% (n=93) for the postal questionnaire. 
Findings were similar to those of previous research (Brooks et al. 2001b, Luker et al. 
1997) in that patients were generally positive about nurse prescribing, were confident in 
the nurses’ ability to prescribe and believed that access to medicines was improved. 
Most expressed no preference for seeing a doctor or a nurse for the prescription of 
medicines, although there were conditions for which patients would prefer to see a 
doctor. The questionnaire asked patients to rate various aspects of the consultation, 
including aspects of communication and concordance (the findings related to 
concordance were published in detail 3 years later, Latter et al. 2007). All aspects 
relating to concordance were rated positively by the vast majority (over 70%) of patients. 
Patients also highly rated the instructions given on how to take medicines, that the nurse 
checked their understanding, explained the nature of their condition or treatment and 
listening skills. However fewer patients reported to have received clear instructions of 
possible side effects (48%), explanations of risks and benefits (39%) and making 
informed choice about the management of their condition (45%). The study raised
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questions about the extent of corroboration between nurses self-reported communication 
skills and feedback from patients.
b) Doctors
Two studies explored the views of doctors involved in supporting or mentoring nurse 
prescribers (Avery et al. 2004, Latter et al. 2005). The study by Avery et al. (2004) 
involved interviews with 12 doctors (6 General Practitioners (GPs)) and 6 hospital 
doctors) who had supervised nurses through the prescribing program in one health 
region in England (data collection period unspecified). Most of the doctors had been 
asked directly by a nurse to provide supervision and supervisory arrangements were 
facilitated by the existence of professional working relationships founded on mutual 
respect and understanding of each other’s roles. Most were confident that nurse 
prescribing encouraged safe practice, although some limitations were noted. In general, 
doctors viewed the benefits of nurse prescribing (in terms of service efficiency, 
enhanced learning and improved relationships) as offsetting the personal cost in 
volunteering time for supervision. While happy to provide ongoing supervision, it was 
considered important that doctors’ time be taken into account. Few had any experience 
with CMPs. The case study by Latter et al. (2005) included interviews with doctors at 10 
nurse prescribing case sites. As the sites were under different health trusts this study 
allowed for greater generalisation than the study by Avery et al. (2004). Similar findings 
were reported; doctors were positive about nurse prescribing and confident in the 
nurses’ knowledge for prescribing, however their views were confined to those nurses 
with whom they worked and were not extended to nurses in general. As with the study 
by Avery et al. (2004), experiences of mentorship were positive, however time 
commitment issues were reported. There were mixed reports about the impact on nurse
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prescribing on doctors’ workload and nurses were generally considered to take more 
time than doctors within consultations.
c) Other stakeholders
Attitudes of directors of nursing towards nurse supplementary prescribing in psychiatric 
settings were sought through a questionnaire survey of all mental health NHS trusts in 
England (Gray 2005). Directors of nursing were considered to play a central role in 
implementing nurse prescribing within NHS trusts. The 32 item questionnaire was 
designed for the study and included factual questions as well as questions on attitudes 
towards the adequacy of training, benefits and barriers to nurse prescribing. 
Questionnaires were sent to directors of nursing in all 83 mental health trusts in England 
in March 2004. A response rate of 54% was achieved (n=45). The majority of 
participants were positive about the benefits of nurse supplementary prescribing within 
mental health in terms of improving the experience of service users (68%) and patient 
care (57%), but only 33% thought it would improve access to medicines. Fewer 
participants thought supplementary prescribing would be useful in acute and adult 
inpatient care than did for community, outreach and drug and alcohol service settings. 
The feedback that participants had received about the prescribing course was positive, 
however only 42% felt it adequately prepared nurses to undertake the prescribing role. 
The need for additional training in medicines management was reported. Most 
participants reported that consultant psychiatrists had a positive attitude towards nurse 
prescribing but that more preparation to act as mentor or supervisor was required.
A small action research study demonstrated misunderstanding about the nurse 
prescribing role by community pharmacists (Pleasance & Brownsell 2004). Prescriptions
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issued by a nurse prescriber (EFNP) for a consecutive sample of 30 patients visiting a 
walk-in-centre were tracked to the point of dispensing. Findings were that one third 
(/7=10) of these prescriptions were challenged by pharmacists due to a failure to 
understand the legal framework for EFNP. Six of the patients were advised that the 
nurse was prescribing illegally. The potential negative implications of this on patient 
safety and confidence are pointed out by the authors who go on to describe how a 
collaborative approach to clarifying roles and managing change eventually resolved this 
issue. Although the study design was limited, given the small sample, it provides 
evidence of how misunderstanding of nurse prescribing can directly affect practice.
2.5.5 Views o f nurse prescribers
Three studies explored the views of nurse prescribers. These were a small qualitative 
study exploring EFNPs views and experience of prescribing (Travers 2005), a 
questionnaire survey of students undertaking the prescribing qualification (Bradley et al.
2005), and a national questionnaire and case study interviews with EFNPs (Latter et al.
2005).
Bradley et al. (2005) aimed to provide background data on recently qualified nurse 
prescribers and to explore their expectations and motivation. Participants were a total 
sample of 91 nurses attending NIP/NSP prescribing training in four cohorts at one 
university in England. The data collection period was 2003 to 2004 and included nurses 
working in community, general practice and hospital settings. The 40 item questionnaire 
was developed by the research team and piloted with 25 students. The main motivation 
for undertaking the course was to advance practice and improve autonomy. Just under 
half (45%) intended to use NIP and 36% NSP. Although participants had not yet gained 
experience in prescribing, the anticipated benefits included: time savings, promoting
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holistic care and improving communication about medicines. There were mixed 
expectations regarding reception by patients and impact on inter-professional 
relationships, with 23% expecting misunderstanding on behalf of colleagues. The main 
concerns about nurse prescribing, reported by 83%, included practical difficulties in 
implementing prescribing (such as problems with communication systems), increased 
responsibility, misconceptions about the role, ongoing support and increased workload. 
Small numbers (under 10) were concerned about diluting the ‘caring’ role, formulary 
limitations, lack of remuneration and political motivation for nurse prescribing. A range of 
interpersonal, clinical, diagnostic and assessment skills were deemed important for the 
prescribing role.
A small qualitative study exploring the views of 7 EFNPs in one PCT was reported by 
Travers (2005). Participants were 2 nurse practitioners, 2 practice nurses, a family 
planning nurse, a school nurse and a midwife. Data were collected through a focus 
group (involving 4 unspecified participants) plus semi-structured interviews, and were 
subject to thematic analysis. It was not stated how the participants were selected or 
when the data collection took place. The study revealed that although nurses were 
positive about their prescribing role, its usefulness was restricted by the limited 
formulary. There was some confusion over the way the formulary was interpreted in 
practice and, for medicines that were not included, nurses had to resort to their formal 
practice of ‘rubber stamping’ whereby a prescription prepared by the nurse was taken to 
the doctor to sign. Confidence to prescribe varied according to the extent that nurses 
were prescribing, the level of diagnostic skill, specialist experience, and the level of 
support provided. Misunderstanding about the nature and scope of nurse prescribing 
amongst some doctors and pharmacists was reported. A need was identified for more 
training in pharmacology within the prescribing course and some nurses had expected
28
the course to include training on diagnostic skills. Support from prescribing mentors was 
valued and a number of CPD needs expressed. In line with Banning (2004), the authors 
suggested that a rethinking of pre-registration nurse training was required in order to 
improve science and pharmacology education.
The evaluation of EFNP reported by Latter et al. (2005) included a national 
questionnaire survey of 246 nurse prescribers, followed by interviews with 14 nurse 
prescribers in 10 purposively selected case sites. A 54 item questionnaire was 
developed on the basis of a literature review (Latter & Courtenay 2004) and sent to a 
random sample of 400 EFNPs registered in 2002/03 by the Nursing and Midwifery 
Council (Latter et al. 2007). A 71% response rate was achieved, which included 14% 
who were excluded from the analysis because they were not actively prescribing. 
Unfortunately the views of nurses who were not using the prescribing qualification were 
not reported. This was the first study to report the views of nurses with experience of 
EFNP/NSP. As with community nurse prescribing, the majority of participants thought 
prescribing improved the quality of care and patient access to medicine. Benefits for 
nurses included better use of skills, greater autonomy and satisfaction. Few 
disadvantages were reported, but role misunderstanding, limitations of the formulary and 
lack of ability to computer-generate prescriptions were the main problems faced. Peer 
support and access to an up-to-date BNF were the main facilitators to prescribing. In 
contrast to Travers’ (2005) findings, the majority were satisfied with the prescribing 
course and medical practitioner support, although a minority (14%) felt the course had 
partially met their needs and 17% were dissatisfied with support received. Pharmacology 
and advanced clinical skills were the most cited unmet needs. Interviews with nurses in 
the case-studies supported the above findings.
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2.5.6 Organisational perspectives
Patterns of the distribution of nurse prescribing across services and factors influencing 
decisions to send nurses to undertake the prescribing course have been the subject of 
two studies (Gray 2005, Larsen 2004).
The results of the survey of directors of nurses in mental health NHS trusts conducted by 
Gray et al. (2005) found that the majority (81%) of the 102 qualified nurse prescribers 
worked in just four of the 45 responding trusts. A further 128 nurses were training as 
prescribers and 24 trusts in all had nurses qualified or training as prescribers. Only half 
of the trusts had a strategy for implementing nurse prescribing, which indicated that the 
views of the directors of nursing (which were generally positive) and the approach of the 
organisation did not necessarily tally.
Larsen (2004) set out to investigate what influenced the development of nurse 
prescribing in rapid or emergency care settings. A pre-piloted questionnaire was sent to 
all nurse managers in Accident and Emergency departments (A & E), Minor Injury Units 
(MIUs) and Walk-in-Centres (WICs) across 5 geographical areas (n=307). A  response 
rate of 62% (n=192) was achieved and the study was conducted in 2003. The findings 
showed variation in the uptake of the extended nurse prescribing course, with greater 
numbers of nurses attending from WICs (71%) than from A & E (30%) or MIUs (11%). 
Approximately half of A  & E and MIU services had no intention of sending nurses on the 
course. A  range of reasons were given for sending nurses on the prescribing course, the 
main reasons being to increase nurse autonomy, improve patient care, improve nurses 
pharmacology knowledge and increase prescribing knowledge. The most frequent 
reason for not sending nurses was that the formulary did not cover enough of the
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medicines required and that it was easier to use Patient Group Directions (PGDs)3, 
which were cited as the most commonly used means for nurses to obtain medication for 
patients. Other common reasons included lack of funding to cover training, the length of 
the course and difficulty finding medical supervisors. Of the 55 qualified nurse
prescribers, only 27 (42%) were actively prescribing. Comments indicated that some 
nurses were not prescribing because of delays in gaining prescribing pads or approval to 
prescribe.
2.5.7 Profile and prescribing patterns o f nurse prescribers
The profile and prescribing practices of nurse prescribers were reported in three studies 
(Bradley et al. 2005, Kimmer & Christian 2005, Latter et al. 2005).
Profiles of EFNPs were provided by Bradley et al. (2005) and Latter et al. (2005). 
Participants from the study by Bradley et al. (2005) were recently qualified as NIP/NSPs. 
The average age was 41 and they had been qualified for an average of 18 years. The 
level of qualification was higher than for nurses on average, with 31% qualified to degree 
level (compared to 10% for nurses in general) and 14% to post-graduate level. W ork 
settings included hospital (40%), community (32%) and general practice (22%),
illustrating the expansion of nurse prescribing beyond community settings. Just under
half (45%) intended to use NIP and 36% NSP.
Nurses surveyed by Latter et al. (2005), were independent prescribers (EFNPs). In 
contrast to the sample reported by Bradley et al. (2005), most participants worked in 
primary or community care settings, 56% were nurse practitioners and most others were
3 PGDs are documents which legally allow medicines to be administered or supplied to groups of patients 
without individual prescriptions having to be written for each patient (Royal College of Nursing 2004)
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senior grade nurses. Level of qualification to degree level was higher than reported by 
Bradley et al. (2005) at over half and 20% at post-graduate level. Excluding the 14% of 
the sample who were not actively prescribing, 19% of the remainder prescribed less than 
five items per week, 42% between 11 and 30 items and 22% over 30 items per week. 
These prescribing rates were higher than those of community nurse prescribers (Luker & 
McHugh 2002, Rodden 2001). The limited formulary was most often cited as a restriction 
on prescribing. The most commonly treated conditions were skin conditions, family 
planning and soft tissue injuries and the majority prescribed antibiotics. Importantly, this 
study was the first to include medical experts’ ratings of nurse-patient consultations. 
These indicated that, in general, nurses were prescribing appropriately on a range of 
clinical dimensions and correctly writing prescriptions. There were some queries 
however, over nurses’ clinical assessment, history taking and diagnostic skills.
Kimmer and Christian (2005) present a review of prescribing practice undertaken by two 
practice nurses in one medical practice in England. The nurses had trained as EFNPs in 
2003 and the review took place for a 6 week period from January to March 2004. In that 
time the nurses saw 744 patients and data was collected on the reason for visit and 
treatment for each patient using a pre-designed form. Findings present a list of over 40 
reasons why patients saw the nurse, the most common being upper respiratory 
infections (11.4%), procedures such as dressings, ear syringing and injections (8.5%) 
and dermatology (7.5%). A third (345) of all patients seen were given advice only, 21% 
received a prescription from the nurse and 31% needed a prescription that could only be 
issued by a doctor (16% of which were for antibiotics). The authors argue that the nurse 
prescribing formulary of that time limited efficiency savings because nurses could not 
independently prescribe for the 31% of patients requiring a doctors’ prescription.
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2.6 Discussion
The review demonstrates that very little research had been published relating to 
NIP/NSP in the period between its inception and the start of my work in 2006. The gaps 
in knowledge were therefore numerous and further work was required in order to profile 
the development of nurse prescribing, determine its impact on practice and explore the 
factors that facilitate or impede it.
Issues raised by research in this review were similar to those reported in the community 
nurse prescribing literature in terms of a) the benefits and advantages, b) the training 
and support needs and c) the barriers and limitations to nurse prescribing. The benefits 
of non-medical prescribing anticipated by the government included improvements to 
patient care, access to medicines, and making better use of the skills of health 
professionals (DH 2006). Indications from this review and reviews of the first phase of 
nurse prescribing (Latter & Courtenay 2004, Banning 2004) were that these benefits 
were being realised. In addition, it seemed that job satisfaction and ability to practice 
autonomously were factors that motivated nurses to undertake the prescribing course. 
The evidence for these benefits continued to be based mainly on self-report from nurse 
prescribers and key stakeholders. Other than the inclusion of observation of practice in 
the study by Latter et al. (2005), no other types of data were reported to confirm these 
benefits.
Barriers to nurse prescribing remained consistent. Alterations to the prescribing 
programme appeared to have improved the adequacy of the training received by EFNP 
and NSPs (Latter et al. 2005), however, shortfalls in pharmacology, clinical assessment 
and diagnostic skills continued to be reported. Other barriers included; limitations of the 
formulary, misunderstanding on behalf of colleagues, access to medical supervision and
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practical problems in implementing prescribing in practice. Similar needs in relation to 
CPD and ongoing support for prescribing were reported for NIP/NSP as for community 
nurse prescribing.
Significant gaps in knowledge were identified in this literature. Firstly, there was a need 
to explore the development of nurse prescribing within specific areas of practice. The 
advent of NIP/NSP meant that nurses could potentially prescribe across a range of 
treatment areas and within secondary care settings as well as primary and community 
settings, but research on the implications of this change was lacking. Basic information 
about the distribution of nurse prescribers across different practice settings or treatment 
areas was absent. While the study by Bradley et al. (2005) identified nurses studying to 
prescribe in hospital settings, most of the nurses in the study by Latter et al. (2005) were 
based in primary and community settings. Therefore, further work was required to 
examine the impact on practice and factors affecting the development of NMP in non­
community settings. Questions remained about whether the impact or use of nurse 
prescribing differed according to the setting or context in which nurses prescribe, or the 
mode of prescribing. Advances had been made in evaluating nurse prescribing from an 
organisational perspective in relation to mental health (Gray et al. 2005) and emergency 
care settings (Larsen 2004), however these projects were limited to the views of nurse 
managers. The work by Latter et al. (2005) was the only substantial research on the 
views of nurses with experience of prescribing. No work was identified that explored in 
detail the impact or development issues of nurse prescribing in specific practice or 
disease areas. Similarly, while there were advances in profiling the background, 
educational level and prescribing practice of nurses, there was much scope to extend 
this work.
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Secondly, legislative changes in 2006 abolished the EFNP formulary and enabled NIPs 
to prescribe from the whole of the BNF (with the exception of some controlled drugs). 
This monumental and controversial change (Avery & Pringle 2005) was likely to have a 
major impact on nurse prescribing. The limitations imposed on prescribing practice by 
the EFNP formulary were commonly reported to restrict or prevent nurses from 
prescribing in this review. In addition, the acceptance of nurse prescribing by doctors 
may have altered following this change, given reported safety concerns and fears over 
the ability to regulate this expansion (Cressey 2006). Further research was required to 
examine the implications of this change in legislation and to determine if prescribing 
practice had changed as a result.
Lastly, a third limitation related to the lack of exploratory qualitative work in the area. Of 
particular relevance was the lack of research to explore the views of patients, either 
regarding their views of nurse prescribing or regarding the impact of nurse prescribing 
on patient care. The only study to include patients did so via questionnaire method 
(Latter et al. 2005) which is a less appropriate method by which to explore in depth the 
views of patients as the questions are usually pre-determ in ed by professionals 
(Entwistle et al. 2008).
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3. B ackground  to  the research and publications
3.1 Pain
3.1.1 Background
Unrelieved pain is commonly experienced by people throughout society (The Royal 
College of Anaesthetists & The Pain Society (RCAPS) 2003). Despite evidence that 
unresolved pain is linked to emotional and physical complications and decreased 
functional ability, it remains consistently under-treated (Kaasalainen et al. 2010). 
Effective pain management can improve quality of life, reduce the development of 
complications and prevent unnecessary costs to the NHS (McQuay et al. 1997, Clinical 
Standards Advisory Group 2000, RCAPS 2003). This evidence has lead to efforts within 
the UK and elsewhere to improve the efficiency and effectiveness of pain management 
services in relation to acute pain (The Royal College of Surgeons and College of 
Anaesthetists 1990, McDonnell et al. 2003), chronic or long-term pain (RCAPS 2003, 
McQuay et al. 1997) and cancer pain (The British Pain Society 2010).
A multidisciplinary and collaborative team approach, which includes nursing input, is 
advocated for improving pain control (RCAPS 2003). Nurses play a key role in the 
management of pain across a variety of settings, including in-patient and out-patient 
hospital settings, primary care, oncology and palliative care (RCAPS 2003). A  literature 
review of nurse-led care in the management of acute and chronic pain demonstrated 
that while nurses play a key role in pain management, few studies had examined the 
implications of these nurses adopting the role of prescribing (Courtenay & Carey 2008b). 
Two of the many reasons cited for suboptimal pain management are staff shortages and 
inadequate analgesic prescribing by doctors (Schafheutle et al. 2001, Van Nierkerk & 
Martin 2003). As in other areas of practice, there is therefore a potential for nurse
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prescribing to improve the efficiency and effectiveness of pain management by 
increasing the speed of access to medication where there is limited access to a 
specialist doctor.
It was for this reason that two of the studies undertaken focused on nurse prescribing for 
patients in pain. The first (project A) was a qualitative study designed to explore the 
experiences and views about nurse prescribing of nurses qualified to prescribe for 
patients in pain. The second study (project B) set out to describe the role and prescribing 
practice of nurse prescribers working within NHS hospital inpatient pain services.
3.1.2 Research and publications
Project A: ‘Nurse Independent and Nurse Supplementary Prescribing in Acute and 
Chronic Pain’
Given the lack of literature on the impact of nurse prescribing for patients in pain, a 
qualitative study was designed, the purpose of which was both exploratory and 
evaluative. The study aimed to explore the views of nurses who had adopted the role of 
prescribing for patients in pain. The study objectives were to a) explore how nurses had 
adopted prescribing in this area, b) evaluate any impact that it had on practice and c) to 
explore how the legislation on nurse prescribing of controlled drugs impacted on 
practice. Semi-structured interviews were conducted in 2006/2007 with a purposive 
sample of 26 qualified nurse prescribers working with patients in pain. Nurses were 
selected to reflect settings in which specialist pain nurses worked, including acute 
hospitals, a walk-in-centre, outpatient pain clinics, community clinics and a hospice.
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Thematic analysis resulted in four overarching themes; ‘context’, ‘autonomy’, ‘supportive 
environment’ and ‘teams and relationships’, each with a number of sub themes. It was 
decided that three publications were required in order to give justice to the extent and 
detail of the findings and enable adequate discussion: Paper 1 ‘Benefits of nurse 
prescribing for patients in pain: nurse’s views’ (Stenner & Courtenay 2008a), 
incorporates the theme of ‘autonomy’ and describes how an increase in autonomy, 
enabled through prescribing, had resulted in many benefits. Paper 2 The  role on inter­
professional relationships and support for nurse prescribing for patients in acute and 
chronic pain’ (Stenner & Courtenay 2008b), reported the final two themes ‘supportive 
environment’ and ‘teams and relationships’. This paper explores the implications of 
nurse prescribing on inter-professional relationships and related support needs. Paper 3 
‘A qualitative study of the impact of legislation on the prescribing of controlled drugs by 
nurses’ (Stenner & Courtenay 2007), reported on the theme of ‘context’. It describes how 
the impact of nurse prescribing varied according to the context (including legislative 
context) in which it was used.
Project B: ‘A national survey of nurses who prescribe for hospital inpatient pain’
This study set out to describe and explore the prescribing practice of pain nurses 
working within NHS hospital inpatient pain services. Some 3 years after the qualitative 
study of pain nurses views of prescribing (project A), there was still very little information 
available on a national basis about the number or profile of nurses who prescribe for 
patients in pain. A national survey of Macmillan nurses specialising in cancer and 
palliative care (some of whom provide pain management) had identified that about 12% 
had trained as independent prescribers, but that only half of these were actively 
prescribing (Ryan-Woolley et al. 2007). The extent and use of nurse prescribing in other 
areas of pain management (such as chronic pain clinics and acute pain teams) was
38
unknown. The decision to focus on nurse prescribers who worked within hospital 
inpatient pain services was made on the basis of the findings of Project A (Paper 3), that 
these nurses were actively prescribing for patients in pain. In addition, a drive to promote 
the development of acute pain services in an effort to improve post-operative pain 
management had resulted in a series of research publications in this area which 
provided background information about these services (Clinical Standards Advisory 
Group 2000, McDonnell et al. 2003, Nagi 2004, Powell et al. 2004 and Powell et al. 
2009).
The initial plan was to survey nurses following amendments to the legislation on 
prescribing of controlled drugs by independent nurse prescribers, as the findings of 
paper 3 suggested that prescribing practice of these nurses would be affected by this 
legislation. After waiting over a year for this legislation to be enacted, it was decided to 
go ahead with the survey. This was fortunate as the legislation had still not been 
amended at the time of writing. The study resulted in one publication, Paper 4: ‘Nurse 
prescribing for inpatient pain in the United Kingdom: a national questionnaire survey’ 
(Stenner et al. 2011a).
3.2 Dermatology
3.2.1 Background
Skin disease affects around a third of the population and is one of the most common 
disorders encountered by health professionals (Dermatology Workforce Group 2007). 
The majority of patients with dermatological conditions are treated within primary care 
making up about 15% of a general practitioners workload (DH 2007b), and only 2 to 3% 
need to be seen by a specialist in secondary care, usually by outpatient appointment 
(Courtenay et al. 2007a).
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Nurses play a key role in the treatment of patients with dermatological conditions and 
there is evidence that nurse-led interventions improve outcomes for these patients 
(Courtenay & Carey 2007). An integral part of the nursing role in dermatology is to 
ensure that patients have sufficient information and confidence in order to self-manage 
their condition. This includes demonstrating the application of topical treatments and 
providing physical and emotional support to patients and carers (Dermatology Workforce 
Group 2007). In their review of the literature regarding the impact and effectiveness of 
nurse-led care in dermatology, Courtenay & Carey (2007) found nurses to be involved in 
the care of patients in a variety of inpatient, outpatient and community settings. 
Community and primary care based nurses commonly saw up to 5 patients per week 
with skin conditions and a range of treatments were supplied or administered to patients 
by nurses working in dermatology units. Given the extensive nursing contribution and 
wealth of experience in dermatology, these nurses have been considered to be in a 
good position to adopt the prescribing role (Dermatology Workforce Group 2007). By 
doing so, nurses can potentially contribute to improving access to services that are 
under strain due to increasing demands in general practice and the shortage of 
specialist care provision (DH 2000, British Association of Dermatologists & Royal 
College of Physicians. 2008, DH 2007a).
Skin conditions were identified as the most common conditions prescribed for by nurses 
in a national survey conducted by Latter et al. 2005. A survey specifically examining 
nurse prescribing for dermatology patients was conducted in 2005 (Courtenay et al. 
2007a, Courtenay & Carey 2008c, and Carey et al. 2007). This postal questionnaire was 
sent to 1,187 qualified EFNP/NSPs (now known as NIP/NSP) registered on a database 
for a medical reference guide for nurses. This constituted around 25% of the population
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of registered qualified nurse extended/supplementary prescribers at that time. A 
response rate of 73% was obtained. Of the 868 respondents, 638 (73.5%) prescribed 
medicines for skin conditions. The survey provided important information about the 
profile and prescribing activity o f these nurses along with feedback about the prescribing 
course. In line with patterns of service delivery, 90% worked in primary care, 5% in 
secondary care and 5% across primary and secondary care. General practice based 
nurses made up 58%, specialist nurses 23%, community nurses 10% and senior nurses 
9% of the sample. Respondents were highly experienced: 88% reported more than 10 
years post registration experience. Over half (55%) were educated to degree level and 
19% to above degree level. Almost all (94.8%) had prescribed independently and 37% 
had used supplementary prescribing, although information about current prescribing 
practice or the extent of non-active prescribers was not reported. The level of specialist 
dermatology training undertaken varied; the majority (68%) had attended study days but 
few (under 7%) had completed diploma, degree or masters level courses in 
dermatology. Results from those nurses prescribing independently suggested that a 
broader range of medications and conditions were prescribed for, at a higher frequency, 
by nurses with higher levels of qualification and specialist training and those based in 
primary care (Courtenay et al. 2007a). The survey also identified barriers that nurses 
had encountered to implementing nurse prescribing. These were (in order of frequency): 
problems initiating or implementing CMP’s for NSP, lack of doctor/pharmacist 
understanding, access to doctor, lack of peer support, local arrangements (e.g. for 
obtaining prescription pads) and own clinical knowledge (Carey et al. 2007).
Given the lack of relevant literature on nurse prescribing in dermatology, further work 
was called for to explore in more detail its impact within the practice settings in which 
these nurses worked (Courtenay et al. 2006).
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3 . 2.2  Research and publications
Project C. ‘An evaluation of Nurse Independent and Nurse Supplementary Prescribing in 
dermatology’
Project C was a multiple case-study of 10 practice settings across England in which 
nurses prescribed medicines for patients with dermatological conditions. The project was 
intended to follow-up in more detail the practice and impact of nurse prescribing in 
dermatology outlined in the questionnaire survey reported above (Courtenay et al.
2006). The study design, aims, methods and main findings are presented in supporting 
papers S1, S2 and S3. The methods of data collection were video-recorded 
consultations between patients and nurse prescribers, interviews with nurses, doctors 
and receptionists, patient questionnaires and prescriptions issued by nurses. The 
complexity o f the study necessitated that a series of publications were produced in order 
to do justice to the depth of findings.
Supporting paper S1 presents the main findings resulting from triangulation of data from 
the different sources (interviews, consultations and patient questionnaires). These 
findings are presented in three themes; 1) listening to patients and relationships, 2) 
access and continuity and 3) medicines information and shared decision-making. 
Findings from interviews with nurse prescribers are reported in paper S2 and findings 
from interviews with all stakeholders on the impact of nurse prescribing are presented in 
S3. A further publication reports on the analysis o f prescriptions issued by nurse 
prescribers (Courtenay & Carey 2008a). The publication that I am submitting from this 
work is Paper 5 ‘Nurse prescribing in dermatology: doctors' and non-prescribing nurses' 
views’ (Stenner et al. 2009). This paper explores stakeholder views about nurse
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prescribing with a view to understanding the acceptability o f nurse prescribing in this 
setting
3.3 Diabetes
3.3.1 Background
Diabetes is a chronic and progressive disease that affects over 3% of adults in the UK 
(NHS Health and Social Care Information Centre 2005). Concerns about the increasing 
prevalence of diabetes and the subsequent demand on services led to a drive by the 
government to raise the profile o f diabetes across the UK. A national audit of UK 
diabetes services (Audit Commission 2000) identified shortfalls and variation in the 
provision of care and informed the development of a National Service Framework (NSF) 
for diabetes (DH 2001). The Diabetes NSF set national goals and standards with the aim 
of improving services in line with the Government agenda for modernising the NHS (DH 
2000). There have since been a number of revisions of the Diabetes NSF (DH 2010), in 
addition to other guidance (NHS Health and Social Care Information Centre 2005, The 
NHS Information Centre 2010, Healthcare Commission 2007). Throughout this literature 
is an emphasis on the importance of a multi-professional team approach to providing 
good quality, patient-centred care, central to which is the role of the diabetes nurse.
A  review of nurse-led care in diabetes conducted in 2006 found that nurses were 
involved in many aspects of care, including medicines management, education and the 
promotion of self care (Carey & Courtenay 2007). It highlighted evidence that nurse-led 
diabetes care can lead to improvements in glycaemic control, length of stay and cost 
effectiveness of services. However, the review identified a lack of research evaluating 
nurse prescribing. Following this review, a national survey of nurse prescribing was 
conducted in October to December 2006 which included a detailed exploration of the
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background and prescribing practices of nurses who treated patients with diabetes 
(Courtenay & Carey 2008d, Carey & Courtenay 2008, Carey & Courtenay 2010). A 
random sample of 1992 nurses registered on a Nursing and Midwifery Council (NMC) 
database of NIP/NSPs were sent a postal questionnaire. The database held details of 
just under 8,000 NIP/NSPs qualified at that time (approximately 25% of the total 
population of NIP/NSPs). O f the 1377 completed questionnaires returned, 439 (32%) 
prescribed for patients with diabetes.
The national diabetes nurse prescriber survey (Carey & Courtenay 2010) found patterns 
of job titles, work setting, background experience and qualifications for diabetes nurses 
that were very similar to dermatology nurse prescribers (as described in section 3.2.1). 
The majority of respondents (84%) were based in primary care, 10% in secondary care 
and 6% worked across primary and secondary care. Practice nurses and nurse 
practitioners made up 63% of the sample, specialist nurses 18%, community nurses 
14% and senior nurses 5%. More than 5 years prior experience in practice was reported 
by 75%, 56% were educated to degree level and 25% higher than degree level. Over 
half (55%) had undertaken specialist training at diploma level or higher, compared to 
less than 7% of dermatology nurses. Methods of prescribing were sim ilar to those 
reported by dermatology nurses, 93% had used independent and 50% supplementary 
prescribing. Of those using NIP, senior or managerial nurses and community nurses 
tended to prescribe fewer items per week than specialist and general practice based 
nurses, with the majority of the sample (52%) prescribing between 1 and 5 items per 
week (Courtenay & Carey 2008e). Products prescribed most often via NIP were oral 
anti-diabetic drugs, monitoring products, lipid regulating drugs and insulin. Between 40% 
and 70% of the sample also prescribed medication for various diabetes related
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conditions such as skin infections and cardiovascular disease and it was the general 
practice-based nurses who prescribed the broadest range of products.
As well as building a profile of diabetes nurse prescribers, the survey provided 
information on benefits and barriers to nurse prescribing. The majority of respondents 
thought nurse prescribing had a positive impact on patient access to medicine, quality of 
care, use of professional skills and job satisfaction. Barriers to prescribing were (in order 
of frequency): a) lack of CPD or prescribing knowledge, b) lack of resources, poor 
communication and other (non-specified) practical problems, c) restrictions placed on 
prescribing by employer, and d) lack of support from clinicians or pharmacists. However, 
over 80% had accessed CPD to support their prescribing role, the main barriers reported 
by the remaining 20% being lack of facilities or funding for CPD.
A similar profile of nurses who prescribe for patients with diabetes has since been 
reported via an online survey conducted in 2009 (Courtenay & Gordon 2009). Five- 
hundred and forty six (62%) of the 878 members of the Association for Nurse 
Prescribing (ANP) who were emailed the questionnaire responded, of which 35% 
prescribed for patients with diabetes. Of these nurses, 49.7% were based in primary 
care, 7.4% in secondary care and 16.7% worked across both primary and secondary 
care.
3.3.2 Research and publications
Project D: ‘An evaluation of Nurse Independent and Nurse Supplementary Prescribing in 
diabetes’
A case study design along the same lines as project C was chosen to explore and 
evaluate nurse prescribing in relation to diabetes services. The case study was of 9
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practice settings across England in which nurses (n=10) prescribed medicines for 
patients with diabetes. Data included semi-structured interviews (n=31), patient 
questionnaires (n=131), videotaped observations of nurse consultations (n=35) and 
prescriptions issued by nurses (a?=19).
The wealth of data generated by the study necessitated multiple publications. Findings 
resulting from triangulation of interview, questionnaire and observation data are 
presented in supporting paper S4. Results of the prescription analysis are presented in 
paper S5. Stakeholder views about the nurse prescribing programme are presented in 
S6. Paper S7 explores how nurse prescribing impacted on the diabetes services and 
team relationships. Interview data relating to the implementation of nurse prescribing 
and its impact on the role o f the nurse is presented in Paper 6 ‘Implementing nurse 
prescribing: a case study in diabetes’ (Stenner et al. 2010a) and Paper 7 ‘How nurse 
prescribing influences the nursing role’ (Stenner et al. 2010b).
Project E: The  views of diabetes patients on their relationship with nurse prescribers in 
primary care’
Although patients were included in the previous case study of nurse prescribing in 
diabetes, this was confined to a short patient questionnaire that asked patients to rate 
satisfaction with various aspects of the nurse prescriber consultation. Little research had 
been undertaken with patients of NIP/NSP nurses. In order to better understand the 
dynamics of relationships between patients and nurse prescribers and to explore 
patients’ views about nurse prescribing, a qualitative interview study was planned.
This was a qualitative study involving semi-structured interviews with patients with 
diabetes who had been treated by a nurse prescriber in primary care. A total o f 41
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patients were recruited from the case-loads of 7 nurse prescribers in different locations 
in England. A thematic analysis was conducted on the data.
Two publications were produced, one (S8) relating to patients views on the acceptability 
of nurse prescribing (Courtenay et al. 2010) and Paper 8 Consultations between nurse 
prescribers and patients with diabetes in primary care: a qualitative study of patient 
views’ (Stenner et al. 2011 b).
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4. D iscussion
The discussion that follows will demonstrate the contribution made by the publications to 
knowledge in relation to nurse prescribing and the implications for practice. 
Methodological issues relevant to this work are then discussed, followed by a discussion 
of the contribution to theory. Lastly, there is a description of how the work has been 
disseminated and evidence of its impact in the field of study.
4.1 Contribution to knowledge
The body of work presented forms an evaluation of nurse prescribing which takes as its 
focus the views of key stakeholders with experience of nurse prescribing within three 
specific areas of practice; pain, dermatology and diabetes. The main publications 
contribute to a national profile of nurse prescribing for inpatient pain (P4) and an 
exploration of the views of nurse prescribers (P I, P2, P3, P6, P7), patients (P8), doctors 
(P5, P6, P7), non-nurse prescribers (P5, P6, P7) and administrators (P6) on the impact 
and implications of nurse prescribing. Supporting publications (S1 to S8) relay additional 
study findings related to the main publications and are drawn upon to elaborate these 
findings where relevant. Supporting publications contribute to evaluating the 
appropriateness and safety of nurse prescribing for dermatological conditions (S1) and 
patients with diabetes (S4, S5), stakeholders views on the acceptance of nurse 
prescribing (S1, S2, S3, S6, S8) and the impact of nurse prescribing on service 
development (S7).
This discussion will focus on three main knowledge areas in which the publications have 
contributed: a) understanding the impact of NIP/NSP on patient care and inter­
professional relationships, b) exploring the influence of nurse prescribing on advancing
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nurse roles and c) identifying factors that influence the uptake and use of nurse 
prescribing. Implications for practice are noted throughout and then summarised at the 
end.
4.1.1 Impact o f nurse prescribing on patient care and inter-professional relationships
a) Impact on patient care 
As demonstrated through the review of literature, little was known about the impact of 
NIP/NSP following the expansion of nurse prescribing rights to all qualified nurses and 
the abolition of the extended nurse prescribing formulary. Paper 1 was one of the first 
qualitative publications to address this topic following the extension of prescribing rights 
in 2006. Prior to this, the NPEF contained a limited number of medicines that nurses 
could prescribe for pain and controlled drugs could only be independently prescribed by 
doctors (Mula & Wares 2003). The paper (P1) describes and discusses the many 
benefits reported by 26 nurses who prescribed for patients with pain. Improvements to 
quality of care, access to medicines and to nurses’ job satisfaction concurred with 
evaluations of EFNPs by Latter et al. 2005 and Bradley and Nolan (2007). Similarities 
between these studies and earlier work on community nurse prescribing, confirmed that 
NIP/NSP was appropriate and applicable across a range of settings. Later research on 
nurse prescribing in the treatment areas of dermatology and diabetes identified 
comparable benefits, including improvements to service access, speed, efficiency, 
safety, increased holistic care, improved information provision and choice over 
medicines (S1, S3, S4 and S7).
Importantly, P1 built upon previous work (Luker & McHugh 2002, Rodden 2001) by 
describing the processes through which nurse prescribing impacted on care delivery.
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Prescribing was depicted as having a positive knock-on effect on nursing practice, acting 
as a catalyst to create further benefits. By prescribing directly to patients, nurses were 
able to reduce delay, prevent errors and tailor treatment to the needs of patients. As 
nurses gained more control over the timing of pain medication, they became more 
confident in communicating with patients’ about their medication and this was, in turn, 
thought to increase patients understanding about their medication and improve 
adherence. The consistency of prescribing in the acute setting (where there was a high 
turnover of junior doctors) was reportedly improved, thereby reducing costs and errors. 
By identifying these processes, P1 not only provided evidence to support the 
development of nurse prescribing in this setting, it also identified a range of process and 
outcome variables that could potentially be used to measure these benefits. For 
example, nurses reported that they were better able to directly provide evidence-based 
pain treatment through prescribing and that, through their educating role, were better 
able to promote its use; a finding that was reported again in Paper 4. This would indicate 
that measurable changes in practice would be expected to occur, for example, where 
there is a specialist pain nurse prescriber working in an inpatient pain team. Identifying 
the links between particular nursing activities and care outcomes is of increasing 
importance in a policy climate where there is need to demonstrate cost-benefits and 
impact on healthcare outcomes in order to justify funding (McWilliam 1994). The findings 
may help direct future investigators with regards to where to focus efforts to measure 
such outcomes.
A further contribution of P1 is its theoretical analysis o f how the benefits of nurse 
prescribing related to the greater autonomy of practice that it enabled. In this respect, 
the paper advanced on previous publications by theorising about how and why these 
benefits come about. The theory proposed in P1 builds upon an idea advanced by
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Bradley and Nolan (2007) that prescribing, rather than simply being an ‘add on’ or 
extension to current roles, enables nurses to provide more holistic care through adopting 
prescribing alongside more traditional ‘caring’ roles. In P1, nurses’ specialist knowledge 
of pain medication, their practical experience of how medications work in different 
situations, and their inter-active and holistic approach to consultations, were said to 
combine to enhance ability to prescribe appropriately, therefore improving quality of 
care. Rather than simply providing a substitute service to that of a doctor by transferring 
the prescribing function to a nurse, the findings imply that patient care may actually be 
enhanced through nurse prescribing. This issue was noted by Spilsbury and Meyer 
(2001) following a review of literature on nursing outcomes, skill mix and changing roles. 
These authors argue that, because of the different set of skills and experiences that 
nurses have, it is wrong to assume that nurses who adopt medical tasks will provide 
care in the same way as doctors. The possibility that patient care and outcomes could 
be enhanced by new nursing roles, or that the care provided may be substantially 
different to that provided by doctors, should be taken into account when evaluating or 
comparing roles (Spilsbury & Meyer 2001).
While there was agreement between different health professionals over the beneficial 
aspects of nurse prescribing (P1, S1, S3, S4 and S7) a detailed examination of the 
views of patients about NIP/NSP was lacking. Paper 8 and supporting paper (S8) made 
a significant contribution to knowledge by reporting on the views of patients on their 
experiences of being prescribed medicines by a nurse. The two papers (P8, S8) were 
the first to report on the views of patients with diabetes who had been treated by a 
NIP/NSP. Of major importance was the alignment between views of patients and other 
stakeholders over the impact of nurse prescribing; nurses’ approachability, rapport and 
ability to give clear information made it easier for patients to ask questions and helped to
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ensure that treatment and advice was appropriate to the individual (P8). Ultimately, this 
improved concordance between patients’ and nurses’ understanding of treatment and 
patients’ ability to self-manage their condition. Speed of access to medications had 
improved, as had the ease of gaining advice in non-routine situations, which was aided 
by the opportunity for telephone contact with the nurse. As with previous research 
(Brooks et al. 2001b, Latter et al. 2005), participants were accepting of nurse prescribing 
and believed it to be beneficial with very few disadvantages. This accumulation and 
consensus of findings between different stakeholders and within different areas of 
nursing practice gives strength and validity to the evidence (Yin 1994).
Importantly, paper 8 expanded upon previous questionnaire research (Latter et al. 2005) 
to give a detailed description of what patients considered to be the most valued aspects 
of the care they received. Patients’ values are often ignored in preference to the opinions 
of professionals when it comes to defining and evaluating what constitutes a good 
service (Entwistle et al. 2008, Spilsbury & Meyer 2001). The findings reported in paper 8 
are compared against a framework of person-centred nursing developed by McCormack 
and McCance (2006). It was found that the way patients described the care received by 
a nurse prescriber was largely compatible with the processes, outcomes and nurse 
attributes required for person-centred care (McCormack and McCance 2006). This 
reinforces the necessity for nurse prescribers to be skilled in the practice of patient- 
centred principles and to have up-to-date knowledge and experience in their area of 
prescribing in order for NMP to be beneficial to patients. Other key influential factors 
were flexibility over the length of consultation and ability to build a relationship over time 
through continuity of care. It is therefore important that consideration be given to training 
to develop the person-centred skills of health professionals, together with environmental
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factors (such as length of consultation) that facilitate person-centred care, in order to 
provide the kind of service that patients’ value.
b) Impact on team relations and service configuration 
It was anticipated that NMP would lead to improvements in skill mix and flexibility in 
teams (DH 2006), however Bradley and Nolan (2007) noted a lack of evidence regarding 
the impact of nurse prescribing on team working and relationships. Paper 2 helped to fill 
this gap through its focus on the impact and relevance of inter-professional relationships 
in relation to nurse prescribing in pain. The paper identified that nurses’ relationships 
with other health professionals served multiple functions. In line with previous research 
(Otway 2001), having the support of clinicians and peers was deemed crucial to 
providing a positive supportive environment for nurses to build their confidence, 
experience and continued learning in relation to prescribing. At the same time, nurses 
played an important educational and facilitative role, using their prescribing knowledge to 
improve understanding and consistency of pain management amongst other health 
professionals and contributing to a learning environment within teams. Where such a 
supportive environment was present, nurse prescribing helped to accelerate clinical 
learning within teams.
Further evidence of the impact of nurse prescribing on team relationships and service 
configuration is discussed in relation to dermatology (P5, S1, S3) and diabetes (P6, P7, 
S4, S7). There was a consensus amongst stakeholders that nurse prescribing reduced 
the number of times that doctors were interrupted to sign prescriptions (P6, S3), as had 
been noted in previous research (Latter et al. 2005, Luker & McHugh 2002, Lewis-Evans 
& Jester 2004). In addition, the workload of some doctors had changed to include more 
patients with complex care needs in dermatology (S3) and diabetes services (S7);
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although nurse prescribing was not considered the only cause of this change. There was 
considerable impact as nurse prescribing had become integral to service re-design 
within dermatology, increasing capacity and reducing waiting times (S3). In contrast, 
within diabetes services where nurse-led services were already established, 
respondents found it difficult to distinguish the impact of nurse prescribing from wider 
changes that were underway within diabetes services (P6, S7). Across the board there 
was agreement between stakeholders that nurses were able to work more independently 
and complete episodes of care, although the need to continue communicating as a team 
was emphasised, particularly in relation to pain and diabetes services where multi­
professional team working was established (P2, S7). The impact on non-nurse 
prescribing colleagues and administrators was mixed in both settings, indicating that 
practice context (such as access to a medical prescriber) is a key determinant (Pô, S3). 
These findings suggest that the anticipated benefits of making better use of existing skill 
and increased flexible working within teams (DH 2000, 2006), were being realised, 
although to varying extent in different contexts.
4.1.2 Impact o f prescribing on the nursing role
a) Raising the visibility of nurse prescribing 
The first four papers (P1, P2, P3 and P4) represent pioneering work on nurse 
prescribing for pain in the UK. Together, they provide a full and detailed account o f the 
views of NIP/NSPs on the impact and implications of nurse prescribing for pain. These 
publications help to mark advancements in the role of pain nurses in prescribing 
medication for patients thereby making the role more visible. It has been argued that 
many aspects of nursing work are hidden and remain largely unrecognised and 
unacknowledged (McWilliam 1994, Spilsbury & Meyer 2001). One of the first steps
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towards recognising and measuring the contribution that nurses make to health services 
is to provide a description of the numbers of nurses working in a particular area of 
practice and their work profile (Johnson 2001). Paper 4 was the first to present such a 
profile of nurse prescribers working in NHS hospital pain services and therefore provides 
essential background information about these nurses. As the survey was designed to 
enable comparison with previous data on nurse prescribing, it drew attention to the high 
level of specialist education amongst pain nurse prescribers compared with other nurses 
(Courtenay & Carey 2008c). Given that the acceptance of nurse prescribing by key 
stakeholders is dependent on nurses having an appropriate level o f training and 
experience (P5, P6, P8); this important finding should provide reassurance. 
Furthermore, by looking at prescribing alongside other aspects of the pain nurse role, 
and detailing the estimated time spent on key activities, paper 4 contributes to 
understanding the impact of prescribing on advancing this nurse role. This is of 
importance given the lack of information on the role of the pain nurse (Williamson-Swift
2007) and the general lack of knowledge about changing patterns of clinical practice 
within advanced nurse roles (Gardner 2010).
b) How nurses benefit from the prescribing role 
From the early days, nurses have been reported to benefit from adopting the prescribing 
role through increased job satisfaction and the ability to provide holistic care (Luker & 
McHugh 2002, Lewis-Evans & Jester 2004). The ability to gain autonomy and advance 
practice provided motivation for nurses to undertake the NIP/NSP course (Bradley et al. 
2005). Paper 1 extended understanding of the way NIP/NSP benefited the role and 
practice of nurses who prescribed for pain. Building on the work of Bradley and Nolan 
(2007), P1 discussed how the autonomy offered by independent prescribing gave nurses 
more control over medicines management and enabled them to overcome problems
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within the service and provide complete episodes of care. This led to increased job 
satisfaction, allowing nurses to make better use of their knowledge and experience to 
bring about care improvements. It also facilitated new learning about side-effects and 
drug reactions, increased nurses’ confidence and improved relationships with team 
members.
The importance of autonomy as a catalyst to a range of benefits experienced by nurses 
was repeated in a later publication relating to dermatology nurse prescribing (S2). Along 
with improving job satisfaction, nurse prescribing within dermatology facilitated the 
development of nurse-led clinics and the advancement of nurse roles (S2, S3). 
Interestingly, while prescribing was said to improve and develop practice, this was more 
often reported by dermatology specialist nurses than non-specialists (S2). Prescribing 
also facilitated advancing nurse roles in diabetes (S6), although its impact varied 
according to the nurses’ scope of practice (S7). The impact of prescribing on the role 
and practice of the nurse can therefore vary according to scope of practice and level of 
knowledge and experience. This may reflect differences in the development of nurse 
prescribing in the UK and other countries such as the USA, Canada and Australia, 
where nurse prescribing is closely bound to advanced nurse practitioner roles. Although 
there remains considerable confusion internationally over definitions and standards of 
different advance practice nurse roles (Duffield et al. 2009), there has been greater effort 
to standardise levels of practice and education (often to Masters level) in these countries 
(Ball 2009). In contrast, there is little consistency between job titles, level of practice and 
education amongst nurses in the UK (Daly & Carnwell 2003, Duffield et al. 2009, Wilson- 
Barnett et al. 2000), and the minimum requirement to undertake a nurse prescribing 
qualification is the ability to study at degree level (DH 2006). As a result, there is 
considerable variation in role, education, scope and level of practice amongst nurse
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prescribers in the UK, and indications from this research are that the impact of 
prescribing varies accordingly. Likewise, there are variations in the level of autonomy 
expected of nurse prescribers, for example, a survey of psychiatrists across two UK 
mental health trusts found that significantly more junior doctors than consultants thought 
nurses should not be able to prescribe independently (Rana et al. 2009). Rana et al. 
2009 did not clarify whether the question of ‘independence’ referred to the mode of 
prescribing (i.e. ‘independent’ as opposed to ‘supplementary’ prescribing), or to 
distinctions between initiating treatment as opposed to prescribing repeat medication for 
pre-diagnosed conditions. Mixed views about nurses’ scope of practice and autonomy to 
initiate new treatment were reported by patients with diabetes in relation to nurses with 
specialist and non-specialist roles (P8). This underlines the need to further clarify 
relationships between levels of prescribing practice or autonomy and nurses’ role or 
scope of practice, and how this relates to stakeholder acceptability. Clearly, investigators 
should be wary of treating ‘nurse prescribers’ as a homogenous group with equal 
autonomy. An additional practice implication is that the wide variation in nurses’ scope of 
practice and application of prescribing in the UK is likely to complicate efforts to 
standardise practice, as has been the case with advanced nurse role in general (Duffield 
et al. 2009), with the result that there is likely to be a continuing need to negotiate 
prescribing roles on an individual basis.
c) Disadvantages and concerns 
Increased autonomy is a key motivator for nurses to undertake prescribing (Bradley et 
al. 2005), however not all nurses wish to undertake the course and there are indications 
that specialist nurses working at advanced levels may be expected to do so (P7). Other 
disadvantages to the nurse role included concern about the lack of remuneration for the 
increased responsibility of prescribing (S2), a finding repeated elsewhere (Bradley et al.
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2005, Nolan et al. 2001). Anxiety over increased responsibility was particularly high 
during what was termed the ‘transition period’ when nurses were initiating their first 
prescriptions (P1, S2), although this was reported to subside overtim e.
A widely raised concern about the impact of prescribing, as with other aspects of 
advancing nurse roles (Daly & Carnwell 2003, Spilsbury & Meyer 2001), is that it may 
erode the nursing approach to care in favour of a medical approach. Paper 7, reporting 
on interviews with nurses and doctors, addressed this issue within the context of nurse 
prescribing for patients with diabetes. The paper clarifies how prescribing was adopted 
by nurses whilst maintaining the principles of holistic, patient-centred care considered 
central to nursing and beneficial to the treatment and management of diabetes. While 
aware of potential tensions that could arise when adopting ‘medical’ tasks, nurses 
worked to maintain a distinction between nursing and medical roles. This paper is 
important because it supports and builds upon previous research that described how 
nurses adopt prescribing within a nursing framework (Bradley & Nolan 2007). It 
demonstrates the active process of role negotiation and boundary clarification that 
occurs during periods of role transition (Williams & Sibbald 1999). A  pertinent example 
of such a dispute is given within the paper where a nurse prescriber within general 
practice was asked to reduce the length of consultation to match those of the doctors. 
Findings illustrate that the adoption of prescribing involves more than the acquisition of 
new knowledge and skill, it requires a shifting of power relationships between doctors 
and nurses (Rana et al. 2009) and a reassessment or renegotiation of roles and 
practices. It also reiterates that there are practical differences in the way care is provided 
by doctors and nurses and that nurses may require flexibility over appointment length in 
order to maintain prescribing within a nursing framework.
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A further related contribution made by paper 7 was the distinction between the way 
doctors and nurses were said to make prescribing decisions. Nurses, on the whole, were 
described as being inclined to follow clinical guidance and protocol in their treatment 
decisions. This was generally regarded as positive in that nurses were more likely than 
some doctors to prescribe medicine in line with evidence-based practice guidelines. On 
the other hand, it marked nurse decision-making as inferior to medical decision-making 
in that nurses were considered either less trained or less able to make complex or risky 
decisions. However, there was evidence that diabetes specialist nurses in particular 
were undertaking higher level decision-making on par with that of doctors, in that they 
sometimes prescribed medications outside of standard protocol for patients with 
complex needs. Higher level clinical decision making and the ability to exercise 
judgement and discretion in clinical care are characteristic features of specialist nursing 
practice (Duffield et al. 2009), and it appears that these skills are being applied to 
prescribing decisions. The findings indicate that traditional distinctions between nurse 
and doctor roles are becoming blurred in relation to decision-making but the impact of 
prescribing on nurse decision-making and use of evidence-based practice is unclear. 
What little research exists has been on community nurse prescribing (Luker et al. 1998b, 
Offredy et al. 2008) and is therefore an area that requires further investigation.
4.1.3 Implementation and use o f nurse prescribing
Together, the publications make a major contribution to identifying and understanding 
factors that influence the use of nurse prescribing within the areas of pain, dermatology 
and diabetes. Variations exist in the extent that nurses actively use their qualification to 
prescribe for patients. Lower rates of prescribing, for example, have been reported for 
community nurse prescribers (Hall et al. 2006, Luker & McHugh 2002) than for 
NIP/NSPs (Courtenay et al. 2007b, Latter et al. 2005). Low use of the qualification is
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potentially costly in terms of wasted time and expense in training individuals to prescribe 
(Norman et al. 2007) and may indicate a failure to successfully implement the initiative. 
Therefore, this work contributes to knowledge by identifying the extent to which NIP and 
NSP are being used in different contexts and by exploring the barriers and facilitators to 
their implementation and use.
Paper 4 was the first to present information on the prescribing practices of nurses 
working in NHS hospital pain services. It provides national data on the number of pain 
nurses working in inpatient pain services, the number of these who were qualified to 
prescribe and details of prescribing activity in relation to inpatient pain. In contrast to 
other areas of practice where prescribing activity was reported to be low (Ryan-Woolley 
et al. 2007), the majority of these participants were actively prescribing. Most used NIP 
(89.5%), a minority used NSP (12%) and 10% were not using their qualification. These 
findings confirm that independent prescribing was being successfully used in this context 
following the extension of prescribing rights in 2006, although the extent that nurses 
could prescribe was said to be hampered by legislation on independent prescribing of 
controlled drugs. The contribution to knowledge made by this paper is important given 
the lack of information available on a national basis about the areas of practice in which 
nurse prescribers work or their prescribing activity. This is despite a year-on-year rise in 
the number of nurses qualifying as prescribers (Prescription Services 2010). Although 
there has been a steady increase in the total number of items prescribed by nurses 
(Prescription Services 2010), this data has only been available for prescriptions issued 
within general practice or primary care trusts. The main sources of information on the 
profile and prescribing practice of NIP/NSPs have been independent research 
(Courtenay et al. 2007a, Courtenay & Carey 2008d, Carey et al. 2007, Carey & 
Courtenay 2008, Carey & Courtenay 2010) and national evaluation (Bissell et al. 2008,
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Latter et al. 2005, Watterson 2009). Paper 4 provides essential benchmark information 
that will enable future investigators to measure change in prescribing practice, for 
example, any change that may occur following the expected amendments to controlled 
drug legislation. The need for research in this area was reinforced by the extremely good 
response rate (85%) for this study.
The introduction of advanced nursing roles, such as nurse prescribing, can be fraught 
with difficulty (Lloyd Jones 2005). Identifying which factors facilitate or impede the 
implementation and use of nurse prescribing is fundamental to improving its 
development. Up until this body of research was carried out, there had been little 
exploration of the conditions that supported or impeded the practice of NIP/NSP. That 
which had, identified issues of misunderstanding (Latter et al. 2005, Pleasance and 
Brownsell 2004, Travers 2005), inadequacy of training (Gray 2005, Larsen 2004, Latter 
et al. 2005, Travers 2005), formulary limitations (Kimmer and Christian 2005, Latter et al. 
2005, Travers, 2005) and lack of organisational support (Larsen 2004, Latter et al. 2005, 
Gray 2005). The findings of publications presented here, (in particular P2, P3, P4, P5 
and P6), expand this knowledge by identifying barriers and facilitators to nurse 
prescribing in the areas of pain and diabetes. They provide information on how nurse 
prescribing was being used in different areas of practice and highlight the impact o f the 
extension of nurse prescribing rights that occurred in 2006. The main contributions to 
knowledge and understanding of factors influencing the implementation and use of 
NIP/NSP are summarised below along with the key implications for policy and practice.
a) National legislation and prescriptive authority 
The initial community nurse prescribing formulary had been reported to impede practice 
(Lewis-Evans & Jester 2004, Luker & McHugh 2002, Otway 2002). Paper 6 confirmed
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early reports (Latter et al. 2005) that the NPEF (prior to 2006) also prevented nurses 
from making full use of their prescribing qualification. Since the abolition of the NPEF, 
participants (in P6) reported to be using the prescribing qualification more frequently as 
they were now able to independently prescribe medicines necessary for patients with 
diabetes. This finding backed the justification to abolish the extended formulary on the 
grounds that it constrained benefits to patient care (DH 2006) and marked a significant 
change in the ability of nurses to prescribe independently. A second area in which 
national legislation was found to curtail benefits for patients was the independent 
prescribing of controlled drugs. Papers 3 and 4 provided the first research evidence that 
this legislation was impeding nurse prescribing practice within acute hospital settings. 
Pain nurses working in acute settings, where the pain experienced by patients was often 
difficult to classify, were reported (in P3) to find the legislation confusing, restricting and 
that it introduced inequality of access to pain medication. Evidence that this legislation 
continued to restrict autonomy and reduce the ability of nurses to promote evidence- 
based pain management was provided in Paper 4. The main recommendation made by 
both these publications was that lifting the CD legislation would enable pain nurses to 
provide more effective care on an equal basis to all patients.
b) Mode of prescribing - Nurse Supplementary Prescribing 
One of the advantages of NSP is that it provides the opportunity for nurses to prescribe 
when they do not have the authority to prescribe independently. The findings of 
publications P3, P4, P6 and S2, however, show that use of NSP was low across all three 
areas of practice. This was a new and unexpected finding. While practical barriers to the 
use of NMP had been reported before (Carey et al. 2007, Courtenay & Carey 2008d), 
the use of NMP was considered most appropriate for patients with long-term conditions 
such as diabetes (DH 2006). It was therefore a surprise that little use had been made of
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NSP by diabetes nurses (P6). The main barriers reported in papers 3 (pain) and paper 6 
(diabetes) were the delay of setting up clinical management plans and the in-practicality 
of using CMPs for patients with unstable conditions. Problems in using supplementary 
prescribing for patients with multiple diseases and complex presentations were also 
reported in a study of nurse and pharmacist prescribing (Cooper et al. 2008). In contrast, 
NSP continued to be used in dermatology clinics (S2) because of its additional benefit of 
helping to standardise care provided by different members of the care team. It was also 
reported as helpful to newly qualified prescribers who lacked confidence (Bradley et al.
2007), and as an opportunity to reflect and update treatment guidelines (Cooper et al.
2008), indicating that there continued to be a role for NSP in some contexts. Evidence 
of the variation in use of this form of prescribing was a new contribution to knowledge. 
That prescribing activity had increased since nurses were able to independently 
prescribe for patients with diabetes implied that, despite having some advantages, NSP 
presented a significant barrier which ought to be considered when developing NMP 
elsewhere in the UK and other countries.
c) Organisational and practice context 
The detailed analysis of nurses’ views of prescribing for patients in pain identified many 
contextual aspects that influenced prescribing activity. The key finding of Paper 3 was 
the identification of factors that determined both the extent that nurses could prescribe 
and the impact of the controlled drug legislation on enabling good practice. 
Understanding the interplay of contextual factors that influence nurse prescribing is 
crucial to determining the circumstances in which it will be most useful or successful. 
Even within the one treatment area of pain there were enormous differences in the way 
that nurse prescribing was used in different practice settings. While nurses working in 
acute settings, for example, were able to prescribe for patients, they were restricted by
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the controlled drug legislation. Within palliative care, although there were few legislative 
restrictions, nurses were reluctant to prescribe certain controlled drugs because of 
difficulties in access, potential side effects and follow-up safety concerns. In chronic pain 
clinics, prescribing was mainly restricted by budgetary arrangements between primary 
and secondary care, ability to provide continuity of care, and access to patient records. 
The findings implied that different patterns of use of the prescribing qualification would 
occur for nurses working in chronic pain outpatient clinics, acute settings and palliative 
care settings. This paper therefore identified that the uptake and use of nurse 
prescribing is heavily dependent upon a range of contextual factors, including national, 
organisational, local and individual determinants. It is important that such information is 
taken into consideration by nurses, managers and commissioners when planning to 
implement NMP. Additional arrangements may need to be in place to enable NMP in 
some contexts, for example, within chronic pain clinics, arrangements to fund prescribing 
across care settings would be required.
Papers 2 and 6 extend knowledge and understanding about the infrastructure and 
support required for the successful implementation of nurse prescribing as initially set 
out through research on community nurse prescribing (Humphries & Green 2000, Luker 
& McHugh 2002, Otway 2001, Otway 2002, While & Biggs 2004). The main findings of 
Paper 2 reiterate the importance of inter-professional relationships and teams in pain 
management and explore how these relationships both supported, and were influenced 
by, nurse prescribing. Paper 6 drew on previous findings about barriers and facilitators in 
order to explore stakeholder views of the implementation of nurse prescribing for 
diabetes services. The two papers report similar findings. Having regular supervision 
and contact with clinicians and peers was crucial to providing a positive supportive 
environment for nurses to build their confidence, experience and continued learning in
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relation to prescribing. However, access to formal clinical supervision was inconsistently 
reported by nurses prescribing for pain (P2) and diabetes (P6). Peer support, the 
importance of which was stressed in earlier research on community nurse prescribing 
(Otway 2002), was also variable (P2, Pô). Nurse prescribing for diabetes and pain was 
facilitated where there was a history o f collaborative working within teams and a 
supportive culture. Nurses reported being better supported where they were able to 
meet with other nurse prescribers through ‘prescribing networks’ or where they worked 
in teams with more than one prescriber. The importance of this latter finding was 
reinforced by later research (S3) that linked reduced isolation and capacity to advance 
nurse roles with the number of nurse prescribers working in teams (Carey et al. 2009b). 
The number of nurse prescribers within teams was identified as important for enabling 
sustained improvement in practice, whereas limited capacity to expand nurse prescribing 
was a barrier (S3).
Organisational processes to facilitate registration as a prescriber, access to prescribing 
pads or electronic systems, CPD and clinical supervision, were facilitating factors in both 
studies (P2, Pô), as were the existence of clear local NMP policy and balanced 
regulation of NMP. Publications Pô, S3 and S9 all found that nurse prescribing was 
facilitated where there was an organisational drive to improve service efficiency and 
where nurses worked within defined roles or within established nurse-led services. In 
addition, the presence of an influential spokesperson or ‘champion’ supporting NMP on 
high level committees (such as the Drugs and Therapeutic Committee) was identified as 
important for promoting NMP at an organisational level (Pô). To summarise, the 
organisational ethos and attitude towards NMP, reflected in the existence of procedures 
to govern, support and develop NMP, was found to be a major factor in determining its 
successful implementation.
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d) Understanding and acceptance 
Misunderstanding of the nurse prescribing role, and direct resistance from colleagues to 
this role, are known barriers to its uptake and use (Bradley et al. 2005, Latter et al. 2005, 
Travers 2005). It is therefore important to know the extent to which key stakeholders 
(including patients and health professionals) accept nurse prescribing. Prior to 2006, a 
handful of studies had reported on stakeholder views of NIP/NSP, only two of which 
used a methodology suitable for exploring views in any detail (Avery et al. 2004, Latter et 
al. 2005). Thus, while patients were widely reported to be happy to be prescribed 
medicines by a nurse (Berry et al. 2006, Berry et al. 2008, W ix 2007), there had been no 
work to explore the conditions attached to this acceptance. Three of the publications 
(P5, P6 and P8) contribute a great deal towards understanding the circumstances under 
which nurse prescribing is considered acceptable to doctors, nurses and patients.
Two publications explored stakeholder views about nurse prescribing with a view to 
understanding its acceptability in the areas of dermatology (P5) and diabetes (P6). 
Participants were doctors and non-nurse prescribers (NNPs) who worked alongside an 
active nurse prescriber. The majority of all stakeholders interviewed were positive and 
accepting of nurse prescribing and a range of benefits were reported. That participants 
in these studies were supportive of nurse prescribing was consistent with previous 
research (Avery et al. 2004, Latter et al. 2005,) and helped to counteract rumours of 
widespread resistance amongst the medical profession (Avery & Pringle 2005). This 
provided evidence that doctors, at least those who worked alongside nurses trained to 
prescribe, were positive about this development, although the findings may not represent 
the views of doctors without such experience. While few disadvantages were mentioned, 
there were conditions attached to the acceptability o f nurse prescribing. Although 
positive about their own experiences of nurse prescribing, participants were wary about
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nurse prescribers in general. Three key criteria were identified as essential to the 
acceptance of nurse prescribing: that nurses have appropriate experience, that they 
work within a defined area of competence and that they demonstrate awareness of their 
limitations. Both papers emphasised that pre-existing working relationships between 
doctors and nurse prescribers helped to alleviate anxieties about nurse prescribing. 
Doctors had more confidence in nurses that they worked with and where they were 
familiar with the nurses’ scope of practice and attitude towards prescribing safely. This 
reflected previous findings (Avery et al. 2004) that good working relationships between 
doctors and nurses facilitated the acceptance of nurse prescribing. By implication, the 
uptake of NMP is more likely to be successful where working relations exist between 
NMPs and doctors prior to its initiation, whereas difficulties may be expected in securing 
the cooperation of medical professionals where such relationships do not exist. Limited 
contact between community pharmacists and doctors, for example, has been noted as a 
barrier to NMP (Ambler 2003).
Interviews with patients revealed similar conditions attached to the acceptability of nurse 
prescribing (P8, S8). Although generally supportive, confidence was strengthened where 
nurses were seen to have a high level of knowledge, good consultation skills, where a 
trusting relationship had developed and where patients had experienced treatment 
benefits. The few concerns expressed by patients were similar to those expressed by 
doctors and non-nurse prescribers as described above, emphasising the need for 
appropriate training and experience, access to CPD and for nurses to work within their 
area of competence and scope of practice. In addition, patients expected nurses to 
continue to work alongside doctors and other health professionals in a team approach, 
regularly communicating changes in health or treatment and referring to doctors over 
complex decisions. The implication being that complete substitution of doctors by nurse
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prescribers would not be universally accepted by patients, as reflected by earlier 
research where patients preferred to see a doctor for what they considered serious 
issues (Brooks et al. 2001b), Similarly, P8 noted that some patients did not expect 
nurses to initiate new treatment or prescribe treatment for conditions other than 
diabetes, while others were happy with this. This finding is a reminder that the 
boundaries of nursing as a profession are not static but are continually being redefined.
It is unclear what lessons can be taken from these concerns and what the implications 
are for policy or regulation of nurse prescribing. Concerns about nurses’ prior experience 
and suitability to undertake the prescribing qualification were already reflected within 
national standards for the selection and governance of NMP (DH 2006). For example, 
these standards recommend that nurses have at least 3 years post-qualifying 
experience (with the final year being in an area of practice relevant to that in which they 
wish to prescribe), that nurses have assessment and diagnostic skills prior to 
undertaking the course, that there is a demonstrable need and agreement that the nurse 
will be able to use their prescribing qualification (DH 2006). If health professionals or 
patients are unaware that these standards are in place, more education to raise 
awareness of them may be required. On the other hand, findings may indicate a lack of 
confidence in the clinical governance procedures to ensure the safety of NMP. Further 
work is required to clarify the extent to which clinical governance procedures and 
policies for selecting candidates to undertake the non-medical prescribing course are 
being implemented within organisations.
e) Preparation for implementing nurse prescribing 
Another important finding, related to stakeholder acceptance, was the crucial role that 
nurses themselves could play in promoting understanding and reducing resistance to
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NMP. This finding was first reported in Paper 2; nurses found it helpful to prepare 
colleagues by explaining how nurse prescribing worked, by having agreed prescribing 
roles and boundaries, and by continuing to challenge any misunderstandings that 
occurred. This was said to reduce confusion and resistance to change, while at the 
same time, facilitated a supportive environment. Similar findings were later reported in 
relation to nurses working in a children’s hospital (Carey et al. 2009b). There were other 
ways that pain nurses were found to manage relationships in order to reduce resistance 
(P2); they also described how they cultivated mutual trusting relationships with clinicians 
over time, aided by a process of explaining rationale for prescribing decisions. This was 
said to improve trust and the quality o f the relationship, thereby improving capacity for 
learning and support. The main implication is that planned preparation for the advent of 
NMP can improve understanding of the NMP role and reduce resistance to it.
The role of the organisation in preparing for and facilitating NMP has been described in 
section ‘c’ above. Additional organisational aspects were identified in P6; through the 
analysis of nurse prescribing in diabetes services, barriers were identified that had been 
resolved through the development of organisational procedures, processes and support 
structures. A number of expected barriers were found not to have occurred in the case 
sites, such as resistance to the development of nurse prescribing and lack of 
organisational and clinical support. Explanations for the absence of barriers included the 
prior existence of established specialist nursing roles and structures to support these 
roles within diabetes services. The implementation of NMP may therefore be facilitated 
where there is a good fit between existing roles and support structures, and those 
required for NMP.
69
Lastly, the adequacy of the nurse prescribing course for preparing nurses to prescribe in 
practice did not arise as a barrier in any of the studies. This is somewhat surprising 
given that it was consistently identified as a problem in previous research (Banning
2004). The absence of this finding may be due to changes to the structure of the course 
and the additional pre-course requirement that applicants demonstrate competence to 
undertake a patient history, clinical assessment and diagnosis (NMC 2006). As course 
prerequisites and guidance have improved (NMC 2006, DH 2006), it could be expected 
that nurses undertaking the prescribing course have more realistic expectations about 
the need to acquire assessment and diagnostic skills, along with specialist knowledge 
and skills in specific areas of practice, prior to undertaking the course. This was reflected 
in nurse and doctor views about the prescribing programme reported in S6 (although 
some variation in course quality was reported). The extent to which organisations adhere 
to guidance on course prerequisites and manage expectations about the course content 
when selecting individuals to undertake the prescribing qualification is an area for future 
research.
4.1.4 Summary o f implications for policy and practice
• Evidence is provided of the benefits of nurse prescribing in pain, dermatology 
and diabetes that can be used by managers and commissioners to inform service 
development and by investigators seeking to evaluate its impact. Benefits for 
nurses including job satisfaction, increased autonomy and enhanced learning 
were confirmed.
• The research reported in the papers describes key standards of care considered 
important by patients with diabetes when prescribed medicines by a nurse, thus 
providing a patient-centred basis for practice.
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• The research reported in the papers identifies a range of factors that managers 
and commissioners need to consider when deciding to initiate NMP, including the 
support required for its implementation. It demonstrates how the impact of 
prescribing on team relations, nurses, and the organisation of care differ 
according to the context in which it is implemented. Contextual variants include 
the extent of pre-established nurse roles and nurse-led services, doctor 
availability, nurses’ scope of practice and level of independent working. This 
provides information to guide development of NMP.
• Prerequisites for the acceptance of nurse prescribing by stakeholders are
proposed. These may inform guidance on the development and clinical 
governance of NMP.
• The research reported in the papers identified areas where support is required to
facilitate role change and development, for example, during the transition to
becoming an experienced prescriber and in negotiating prescribing roles with
team members.
• The research has developed a profile of nurse prescribers working in NHS 
hospital pain services. This provides a benchmark against which the educational 
level, professional background, prescribing activity and role o f similar nurses can 
be compared. Such information can be used to inform development of guidelines 
for nurse prescriber roles, educational requirements and training needs.
• The research indicates that restrictive national or local legislation on NMP can 
deter prescribing and prevent benefits to practice. Abolishing restrictions on NIP 
of controlled drugs is likely to improve patient care provided by specialist pain 
nurses. NSP was found to be of limited use except in situations where, for 
example, CMPs facilitated the coordination of care amongst different prescribers.
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4.2 Investigative approach and methodology
The overall intention of the research was to evaluate nurse prescribing from the 
perspective of key stakeholders. This has been largely set within what Greene et al. 
(2001) call a ‘pragmatic’ view of evaluation. By challenging the privileging of 
metaphysical considerations (questions about truth and nature), the pragmatic approach, 
as proposed by Morgan (2007), rejects the idea that research methods are tied to 
opposing epistemological approaches, such as qualitative methods to constructivism 
and quantitative methods to positivism. Instead, priority is given to selecting the most 
appropriate method to suit the context for the job in hand (Greene et al. 2001). In 
keeping with this type of pragmatic approach, the selection of methods for this research 
was determined by research questions rather than theoretical considerations (Bryman 
2007, Rosenberg & Yates 2007).
A need for evidence to guide the development of NIP/NSP that was applicable and 
relevant to policy and practice was primarily identified through contact with practitioners 
and educators involved in nurse prescribing. The views of nurses were sought to inform 
the design and conduct of the research, both informally (through discussions at 
conferences, meetings and with individual nurses) and formally (through focus groups, 
interview and questionnaire pilots). Involving nurses in the research process helped to 
ensure its validity and relevance as well as building on research knowledge and 
expertise within the NHS.
In terms of methodology, two of the projects used case study approach (Projects C and 
D), two used qualitative methodology (Projects A and E) and one used a survey 
approach (Project B). While all but one (P4) of the principal papers report on interview 
data, a range of data collection methods were used across the projects and are detailed
72
in the supporting publications. The range of methods used is illustrated in Table 2. As 
part of the project research team, the applicant was involved in collecting and analysing 
all forms of data listed in Table 2 to varying extents, as set out in under co-authored 
contributions (pages 9-11).
Table 2. Methods of data collection used across projects
Project reference
Data collection methods A B c D E
Interviews
Patients X
Nurse prescribers X X X
Non-prescribing nurses X X
Doctors X X
Admin/reception X X
Questionnaire
Nurse prescribers X
Patients X X
Structured video observation of nurse- 
prescriber/patient consultation
X X
Prescription assessment X X
4.2.1 Interview study
Most of the publications (P1, P2, P3, P5, P6 and P7) report qualitative data collected 
through semi-structured interview. Qualitative research is a useful means of exploring 
issues about which little is known and for developing or extending social theory (Patton 
1980). The qualitative approach used was based on ‘interpretative’ enquiry, in that the 
aim was to develop explanations based on the interpretations of people within their 
social context (Bryman 2004, Carter & Henderson 2005). An ‘interpretive’ approach has 
been described as one that looks for ‘culturally derived and historically situated 
interpretations of the social world’ (Crotty 2003:67). It is set within a constructionist
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ontology that views social phenomena, such as ‘nurse prescribing’, as concepts that 
people are in the process of fashioning (Bryman 2004). This approach was conducive to 
allowing a detailed exploration of stakeholder views that remained sensitive to the 
complexity of practice and contributed to understanding why benefits arose from nurse 
prescribing in different contexts. Qualitative methodology was chosen for Projects A and 
E because of the lack of knowledge about how nurse prescribing was being adopted in 
relation to prescribing for pain and the limited work exploring the views of patients who 
had been prescribed by a nurse. Furthermore, the rapid expansion of NMP and related 
legislative change meant that the initial research undertaken during the early years could 
not be relied upon to adequately reflect current views on practice.
Thematic analysis was conducted on the interview data. Thematic analysis can vary 
from a simple content description to a detailed exploration of relationships between 
themes (Pope et al. 2006). Its versatility enables it to be set within a number of 
theoretical, ontological and epistemological stances (Braun & Clarke 2006). There is 
general agreement that the aim of thematic analysis is to identify, analyse and report 
common or recurrent patterns or themes (Braun & Clark 2006, Green & Thorogood
2005). The method is therefore useful for identifying which are the salient issues and 
most typical responses. However, it can also be used (as used here) to provide a more 
in-depth analysis, exploring relationships between themes and differences in context 
(Braun & Clark 2006, Green & Thorogood 2005).
The form of thematic analysis used is based upon the guide and criteria for good 
practice and transparency described by Braun and Clarke (2006). It involves stages of 
becoming familiar with the data, coding or indexing transcripts, mapping and identifying 
patterns, comparing and contrasting patterns and identifying themes. This is an inductive
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process whereby the coding frame is developed out of the data, rather than a deductive 
process whereby a coding frame would be developed through theory and then applied to 
the data (Green & Thorogood 2005, Patton 1990). The inductive process, such as is 
used in ‘grounded theory’ (Strauss & Corbin 1990), ensures that findings are ‘grounded’ 
in the data rather than based on prior assumptions, and is particularly suitable for 
exploring new areas and generating theory. In this way, thematic analysis differs from 
another commonly used method of qualitative analysis; ‘framework analysis’ (Pope et al.
2006). With this method, a coding frame is developed early on in the analysis, against 
which the data is coded and interpreted. The analysis is informed by existing knowledge 
or theory, therefore ensuring that findings are relevant to research questions derived to 
inform policy and practice (Bryman 2004). Framework analysis is therefore more suitable 
to research where substantial knowledge already exists within which to frame the 
research findings. A variation of framework analysis was used in paper 6 to analyse 
findings from project D against previous research findings. However thematic analysis 
also differs from traditional grounded theory in that efforts to avoid researcher bias do 
not extend to leaving research questions unrefined, or to not undertaking a literature 
review in advance of data collection. Within my research, I strive to maintain a reflexive 
view of my own involvement in constructing the findings during qualitative enquiry and 
reject the notion that themes somehow ‘emerge’ from the data without any input from the 
analyst (Braun & Clarke 2006).
Qualitative methodology enabled a detailed understanding of nurse prescribing that was 
sensitive to the complexities and variations of context. This provided a solid basis from 
which to develop further research and theory. For example, findings on the advantages 
and disadvantages of nurse prescribing from projects D and E have been used to inform 
a proposal to measure any benefits or change occurring as a result of nurse prescribing
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for patients with diabetes. The disadvantages of this method are described within the 
papers. The main points being that qualitative data is time consuming to collect and 
analyse, therefore it often involves a small sample size which limits the extent that 
findings can be generalised to other contexts.
4.2.2 Questionnaire survey
A descriptive survey design was chosen for project B: (P4), to determine the profile and 
prescribing practice of in-patient pain nurse prescribers. A national survey was 
considered to be the most comprehensive and systematic way of identifying this 
information. The main advantage of survey method is that it enables collection of 
information in the same way from each participant, so that patterns and differences in 
practice can be identified. The survey produced base-line data on the profile and 
practice of these nurses against which comparisons can be made in future studies. 
Another advantage is that statistical inferences and generalisations can be made from 
data collected from a large sample (Bowling 2005). As the views of nurses prescribing 
for patients in pain had already been explored in Project A  (P1, P2 and P3), the survey 
enabled me to determine the extent to which issues identified could be generalised 
across the sample of nurses who prescribed for inpatient pain.
The main limitation reported in the paper was the limited focus of the survey. The survey 
was of nurse prescribers working in inpatient pain teams and asked about their 
prescribing practice within inpatient settings. This was a deliberate strategy to simplify 
the questionnaire (which was already 27 items long) and maintain a feasible sampling 
strategy (which entailed individual contact with acute pain teams). In other words, it 
would have been unfeasible to expand the study to include nurses who prescribed for 
pain in different settings given the time frame and funding available. Information about
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nurse prescribing in chronic pain clinics, palliative care, general practice and community 
settings is still lacking and remains an important area for future research. Other 
limitations of the survey are the problems of the reliability of self-report data and relying 
on memory for estimations of prescribing activity and workload (Oppenheim 1992, 
Robinson 1999).
4.2.3 Case study
The case study design is considered suitable for conducting evaluation in situations 
where there are multiple variables of interest over which the investigator has little 
control, or where the boundaries between phenomenon and context are unclear (Yin 
2003). Nurse prescribing can be considered an innovation that is intended to improve 
health services; however it is also an extension to existing nurse roles. Evaluating nurse 
prescribing is complicated by the fact that prescribing can be adopted by nurses working 
in a variety of roles, within many areas of practice, across a range of contexts and 
settings. As such, NMP can be classed as a ‘complex intervention’ according to 
guidance by the Medical Research Council (MRC) (MRC 2008). To illustrate this, the key 
characteristics of a complex intervention as set out by the MRC are shown in Table 3, 
against which characteristics of NMP are considered.
77
Table 3. Characteristics of non-medical prescribing as a complex intervention
Characteristics of complex 
interventions (MRC 2008)
Characteristics of NMP
Number of, and interactions between, 
components within the experimental and 
control interventions
Fuzzy distinction and overlap between the practice 
of NMPs, non-NMPs and doctors (i.e. the potential 
control and experimental groups). Models of 
working range from a) autonomous, with individual 
case load of patients, to b) continuum of care, 
shared patients and collaborative working within a 
team of health professionals (Drennan et a i 2009).
Number and difficulty of behaviours 
required by those delivering or receiving 
the intervention
Multiple actions or behaviours to consider on behalf 
of NMP (e.g. prescribing, education, health 
promotion, involvement in trust activities, 
prescribing policy) and patient (adherence, self- 
care, understanding, lifestyle)
Number of groups or organisational levels 
targeted by the intervention
Different types of NMPs working in a variety of 
settings and at different levels in the organisation. 
Level of competence and scope of practice varies, 
as do models of practice and characteristics of 
patients treated.
Number and variability of outcomes High number of potential outcomes e.g. inter­
professional working, job satisfaction, advancing 
roles, access to medication, use of evidence-based 
medicine, prescribing errors, efficiency and use of 
services, cost, health outcomes, referrals, 
satisfaction of patient, quality of care, patient 
involvement
Degree of flexibility or tailoring of the 
intervention permitted
Low or no investigator control over intervention. 
Considerable variation in governance, strategy, 
support and development of NMP across 
organisations.
MRC guidance recommends experimental design as first choice for evaluating the 
outcomes of a complex intervention, however it recognises that this is not always 
practical and that observational and process evaluations can make a contribution (Craig
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et al. 2008). Given the extent of the complexity of nurse prescribing outlined in Table 3, 
the mixed-method case study approach undertaken (in projects C and D) was justified.
Mixed-method approaches have been advocated for evaluating complex health 
interventions and social programmes (Greene et al. 2001). Where two or more methods 
are selected to apply to different aspects of the evaluation, the investigator is able to 
explore the complexity o f an innovation from multi-perspectives (Rosenberg & Yates 
2007). Case study is also suitable for evaluating complex programmes or interventions 
where the investigator is asking ‘how’ or ‘why’ questions (Yin 1994). Use o f mixed 
methods is common in case study research (Stake 1998). Indeed, the use of multiple 
sources of evidence is given as the first principle of case study data collection by Yin 
(1994) as it enables the investigator to address multiple perspectives which, when these 
converge, provide more convincing and accurate findings. Case study can be singular or 
multiple in design (Stake 1995). Each case may involve many sources o f data collection 
and may include qualitative or quantitative data. Following lines o f enquiry from different 
sources of evidence, that converge on a single theory or proposition, forms the basis of 
Y in’s (1994) notion o f ‘triangulation’. This is where multiple sources of evidence provide 
multiple measures of the same phenomenon in order to support the validity o f findings.
The disadvantages of this approach are that use of multiple methods is time consuming, 
expensive and demands a range of research experience and skill. Moreover, there is no 
agreement as to how to go about the process of data triangulation, or integrating the 
results o f data collected within seemingly contradictory methodological stances (Bryman
2007). This is one of the main drawbacks of case study and mixed method approaches 
(Wheeldon 2010). Bryman (2007), in an interview study of social scientists who were 
experienced in the use of mixed method research, identified a number of barriers to
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integrating qualitative and quantitative findings. Many o f the investigators interviewed 
had ended up with separate reports for qualitative and quantitative aspects, or had only 
achieved partial integration o f findings. The way this problem was addressed in this 
research was to present the integrated findings in one paper (supporting papers S1 and 
S4) and then to report a more detailed and in-depth analysis o f the qualitative findings in 
separate papers (such as papers S5 and S6). While this overcame the problem of 
finding a way to give justice to the complexity and depth o f the findings, it introduced an 
ethical issue of publishing multiple papers from the same study (Norman & Griffiths
2008). Producing multiple publications is not an ideal outcome and can cause confusion 
to investigators when conducting literature reviews as it is difficult to work out which 
papers results from the same research study. Given the large amount o f data collected, 
particularly through multiple-method case study, it would not have been possible to 
present all the findings in one paper. To account for multiple publications, it was made 
clear (where possible) in each publication whether the full data set or a subset o f study 
findings were being reported and reference was made to additional related publications.
4.3 Theoretical considerations and contributions
Through my work I have sought to build explanations about how nurse prescribing brings 
about various benefits and what conditions are required to support this. In order to 
support the development o f existing theory, reference to relevant work is made, for 
example Paper 6 compares findings to aspects of a conceptual model for considering 
the determinants of diffusion, dissemination and implementation of innovations 
(Greenhalgh et al. 2004). Paper 8 refers to a framework for person centred nursing 
(McCormack & McCance 2006), synthesised on the basis o f two conceptual frameworks 
developed from empirical studies. The framework comprises four constructs: attributes 
o f the nurse that are considered prerequisites for person-centred nursing, the context of
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the care environment, the person-centred processes through which care is delivered and 
the expected outcomes of effective person-centred nursing. The model provided a useful 
basis against which to compare the findings presented in P8 of how patients viewed 
consultations with a nurse prescriber.
The work has also contributed to generating new theory. Generation of theory is in 
keeping with the aims of qualitative research (Bryman 2004, Denzin & Lincoln 2005, 
Strauss & Corbin 1990) and case study (Yin 1994, Yin 2003). Theory development was 
considered by Yin (1994) to be integral to case study design. His approach is 
characterised by the term ‘analytic generalisation’. Unlike statistical generalisation where 
an inference is made about a population on the basis of a sample of that population, 
analytic generalisation occurs when each case study is treated as a new experiment 
through which theory developed around the results of one case can be compared with a 
new case. When two or more cases are shown to support the same theory, 
generalisations can be made; referred to as ‘replication logic’. Analytic generalisation 
through case study enables investigators to explain causal links in real life interventions 
that are too complex for experimental design to capture, or to describe an intervention in 
its real life context. A  similar concept of ‘transferability’ is used by Morgan (2007) to 
summarise the process of testing the extent that findings from one context can be 
applied in another setting within a pragmatic approach.
In the analysis o f how benefits arose from nurses’ autonomy to prescribe, P1 presents a 
theoretical proposition that improvements to patient care will arise where nurses are able 
to combine a) specialist experience and knowledge, b) patient-centred consultation skills 
and c) autonomy to prescribe (Figure 1). From this, it can be predicted that appropriate 
knowledge and experience, good communication skills and the autonomy to prescribe
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are prerequisites, or conditions necessary to cultivate the benefits o f nurse prescribing. 
Where these conditions are present, patient care will be improved beyond that o f the 
simple addition of prescribing to the nursing role. In other words, improvements can be 
expected in concordance, safety and the quality o f care as well as efficiency savings. 
Two-way arrows represent the notion that autonomy to prescribe can also work to 
accelerate learning and enhance communication.
Figure 1. Theory of conditions necessary to cultivate the benefits of nurse prescribing
Autonomy to Prescribe
Patient-centred 
Consultation and 
Interpersonal Skills
Specialist Knowledge
Experience
Benefits
-patient care 
-nurse role 
-team 
-service
Applying the principles o f replication logic to the above theoretical proposition (Figure 1), 
enables comparisons to be made with findings from subsequent publications. Through 
this process, it is possible to identify further factors that influence the impact o f nurse 
prescribing as well as confirming the importance of the factors identified in Figure 1. 
Autonomy was identified as key to a number of benefits o f nurse prescribing within the 
treatment areas of dermatology (S2) and diabetes (S4). The development o f nurse-led 
dermatology services was facilitated by nurses’ autonomy to prescribe, enabling 
specialist nurses to expand their roles and enhance practice in new ways (S2, S3). 
Autonomy was itself strongly influenced by national legislation on prescribing rights (P3, 
P6) and to some extent by the nurses’ role and scope o f practice (S2, S7). Knowledge 
and experience in the area of practice was considered fundamental to the success and
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acceptance of nurse prescribing by stakeholders in dermatology services (P5), and 
diabetes services (P6, P8, S8). Moreover, there was an indication that, because of their 
level o f experience in a dedicated area of work, greater benefits were reported by 
specialist dermatology nurses than by generalist nurses, both in terms o f their own 
learning, and their ability to offer patients a greater choice of appropriate medication (S1, 
S2).
The link between good communication skills and the benefits o f nurse prescribing was 
identified consistently across this work. Stakeholders within diabetes and dermatology 
services considered nurses to be more adept than doctors at communicating well with 
patients (P5, S1, S3, S4). This was said to enhance the effectiveness of nurse-patient 
relationships during prescribing and contributed to holistic care. Nurses themselves 
considered their approach to patient consultations and their communication skills to be 
an advantage when prescribing for patients (P2, S1, S2, S4). An additional factor that 
facilitated communication and relationships between nurses and patients was continuity 
o f care; this finding was reported by all stakeholder groups and across studies (P1, P8, 
S1, S4). Confirmation that nurses consistently demonstrated good communication skills 
within their prescribing consultations were provided through the case study work within 
diabetes and dermatology (S1, S4). Independent assessment o f video-recorded nurse 
prescriber-patient consultations by two consultants in each study confirmed that nurses 
regularly demonstrated key communication skills o f listening, showing sensitivity, 
planning for future need and giving instructions on how to take medication. 
Communication skills based upon nationally agreed competencies for prescribing 
(National Prescribing Centre 2005, National Primary Care Research and Development 
Centre 2003) were also highly rated by patients on all variables set out in the patient 
questionnaire (S1, S3, S4). Finally, the link between nurses’ ability to prescribe, their
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specialist knowledge and their patient-centred approach to consultation, was confirmed 
as being of great importance to patients with diabetes when learning to self-manage 
their condition (P8).
The publications to date support the proposition that combining nurses’ knowledge and 
expertise with a patient-centred approach while prescribing results in benefits. It 
provides an explanation as to how nurse prescribing enables a more holistic approach to 
care as has been reported elsewhere in relation to nurse prescribing (Bradley & Nolan 
2007, Latter et al. 2005). Furthermore there is support for the hypothesis that 
appropriate knowledge and experience, the autonomy to prescribe and good 
consultation skills are prerequisites to successful nurse prescribing. However a number 
of other factors have been identified in these publications as influencing the impact and 
implementation of nurse prescribing and these factors also need to be represented. In 
order to do this, I will now turn to another approach to evaluating complex interventions 
and programmes that is compatible to case study approach; that o f realistic evaluation 
(Pawson & Tilley 1997).
Although the research work presented here was not guided by a realist approach, the 
principles of this approach can be recognised in retrospect and are relevant to the 
evaluation of nurse prescribing. Realistic evaluation is considered particularly suited to 
evaluating complex interventions, although there have been few such evaluations within 
health service research (Greenhalgh et al. 2009, Rycroft-Malone et al. 2010). The 
building blocks of realistic evaluation are the identification of Context, Mechanism, 
Outcome configurations (CMO’s). These are propositions about what causes a particular 
innovation or approach (mechanism), operating within particular circumstances or 
settings (context), to work (outcome). Unlike case study, which can be undertaken under
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a positivist or relativist approach and is argued to have epistemological, ontological and 
methodological flexibility (Luck et al. 2006), realistic evaluation (as espoused by Pawson 
& Tilley 1997) is underpinned by the epistemology of critical realism which is positioned 
between positivism and relativism. Underlying mechanisms are presumed to exist and 
these mechanisms can predict outcomes, however, as the social world is constantly 
changing, these causal mechanisms can never be completely ‘pinned down’ or known. 
Therefore, the aim of a realistic evaluation is not to generate a universally applicable, 
reliable and replicable theory but to generate ‘middle range’ theory. In other words, the 
aim is to develop theory about what works, for whom, why and in what circumstance. 
Propositions (CMO’s), once generated, can be tested through a series o f evaluations in 
order to create a cumulative body o f evidence from which ‘middle range’ theory can be 
developed. This is very similar to Y in’s (1994) idea of analytic generalisation based on 
replication logic.
My research, disseminated through the papers (P1-P8), has been concerned with 
exploring and understanding how nurse prescribing developed in different practice areas 
and the views o f stakeholders on its acceptability and impact. There was an interest in 
identifying any variations or similarities in the implementation and impact o f nurse 
prescribing across different clinical practice areas. These questions were therefore 
conducive to the realist mantra of finding out what works, for whom, why and in what 
circumstances (Pawson & Tilley 1997). The findings clearly demonstrate that a range of 
individual and contextual factors influence the uptake and use of nurse prescribing. It 
seems reasonable therefore to select realistic evaluation as an interpretive framework to 
draw together the theoretical implications o f my work.
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What follows is an overview o f the research implications in which the work could be 
viewed as a cumulative body o f evaluation research from which to generate theory about 
nurse prescribing. This section sets out a series o f propositions about factors that 
influence the impact and implementation of nurse prescribing and thereby determine 
outcomes in different contexts. Following this, I present a framework listing the key 
factors that influence the implementation and use of non-medical prescribing.
4.3.1 Impact of nurse prescribing
Proposition 1 : Legislation and policy (local or national) governing prescribing rights will 
determine nurses' autonomy to prescribe and thereby will influence the impact of 
prescribing
Cumulative evidence has demonstrated that the impact o f nurse prescribing is restricted 
where nurses are unable to prescribe particular medicines or in particular circumstances. 
This has been demonstrated in relation to national and local policy and legislation on 
nurse prescribing. Where restrictions are in place, the ability o f nurses to provide fast 
and effective evidence-based care on an equal basis to all patients is reduced.
Proposition 2: The extent of nurses’ experience and knowledge within their area of 
prescribing practice will influence its impact 
Evidence suggests that where nurses have a good amount o f experience and 
knowledge in the area in which they prescribe the result is an improved service for 
patients. Many patients preferred to be prescribed by such nurses than by doctors who 
did not have the same level o f specialist knowledge. Benefits in terms o f the 
appropriateness, choice and quality o f treatment were reported. It is vital that nurse
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prescribers are able to keep up-to-date with the latest information through continued 
professional development.
Proposition 3: Good communication skills, continuity of care, and the ability of the nurse 
to practice patient-centred care will influence impact 
A main advantage of nurse prescribing as reported by stakeholders is the ability o f the 
nurse to communicate well with patients. Patients valued consultations with nurse 
prescribers for the amount o f care and attention paid by the nurse to their individual 
condition and circumstances, the clarity o f their explanations and their ability to tailor 
treatment to the needs of the individual. Flexible appointment times were considered 
important to enable this ‘patient centred’ consultation style, as was continuity o f care for 
patients with long-term conditions. The reported outcomes included increased 
concordance, improved identification of problems, better quality o f care and more 
efficient treatment.
Proposition 4: The nature of pre-existing roles and service design will influence the 
impact of nurse prescribing 
Differences were reported regarding the impact o f nurse prescribing on service redesign. 
There were indications that changes to service design were less evident where nurses 
already worked in relative independence from the doctor, whereas prescribing facilitated 
more independent working and out-of-hours coverage in situations where this had not 
previously been possible. The extent of existing problems with service design or 
efficiency will influence the capacity for nurse prescribing to reap improvements. Greater 
improvements are likely where, for example, there are delays or problems in gaining 
access to a doctor with the appropriate training or experience to prescribe for that
87
condition, or where there is a high turnover o f medical staff that threatens the 
consistency of care provision.
Proposition 5: The scope of practice of the nurse, and ability to undertake complex 
decision-making will influence the range and extent of impact.
The findings indicate that prescribing is used in different ways by nurses depending on 
their role and scope of practice, for example, the range of medications prescribed and 
the ability to initiate new medication will depend on the level o f training and experience. 
The extent that nurses learn from undertaking prescribing, the opportunities that arise for 
advancing practice and the ability to improve patient care may also differ. There was 
some indication that specialist nurses experienced more benefits in terms of advanced 
learning and practice. Due to their specialist role and advanced level o f practice, 
specialist nurses (such as diabetes nurse specialists) may more often engage in higher 
level decision-making in relation to prescribing than generalist nurses (such as practice 
nurses).
4.3.2 Implementation and use of nurse prescribing
Proposition 1: Uptake and use of prescribing will be determined by contextual factors 
such as national legislation, local policy, finances and organisational or service 
arrangements
National legislation governing the prescriptive authority of nurses will determine the 
extent that nurses can prescribe in different contexts, for example, when prescribing 
controlled drugs. Nurses require local agreement to prescribe which may be restricted by 
organisational NMP policy or local formulary restrictions. A  budget to finance
prescriptions is also required, which may need to allow for prescribing across general 
practices, or primary and secondary care settings.
Proposition 2: A clear understanding about nurse prescribing (on behalf of stakeholders 
and nurses) will facilitate its uptake and use 
Resistance and misunderstanding about the scope of nurse prescribing are key barriers 
to its implementation and use. Preparing staff by providing opportunities to learn about 
and discuss the role o f nurse prescribing can facilitate understanding and acceptance. In 
addition to having support for nurse prescribing within the organisation, nurses 
themselves can play an important role in preparing colleagues and challenging 
misunderstanding. Acceptance is facilitated where the nurses prescribing role is agreed 
in advance of undertaking the prescribing course.
Proposition 3: Good relationships between doctors and NPs will facilitate uptake and 
use
There is evidence that implementation is facilitated where there are pre-existing working 
relationships between doctors and nurses and where nurses are working in clearly 
defined roles. Good relationships increase doctor’s confidence in judging nurses ability 
to prescribe safely and within their area of competence.
Proposition 4: The background (experience and knowledge) of the nurse prescriber, and 
their attitude towards prescribing, will influence whether they are accepted as a 
prescriber by stakeholders 
Nurses with appropriate experience, training and knowledge in the area in which they 
prescribe will be more acceptable to stakeholders. In addition, the nurses’ attitude
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towards prescribing within their scope of practice will influence confidence in their 
practice and acceptability by stakeholders.
Proposition 5: Nurses require access to a range of support for their prescribing role in 
order to implement it successfully 
Nurses require a range of support for their prescribing role, including peer support, 
prescribing networks, access to CRD, clinical supervision, managerial support and 
support from pharmacists. This is crucial for keeping up-to-date with changes in clinical 
practice and for advancing nurse practice. Support is necessary to build nurses’ 
confidence to prescribe, particularly during the transition from novice to experienced 
prescriber. Implementation is facilitated where organisational provision of support is 
provided, however, where this is lacking, the most crucial requirements are peer support 
and clinician support.
Proposition 6: The specificity history and focus of the nursing role will influence the 
uptake and acceptability of NP 
There are indications that nurse prescribing is more easily implemented where existing 
structures and procedures require little adaptation to incorporate prescribing. For 
example, where nurses work relatively independently of doctors, where there are 
comprehensive support networks and where appropriate CPD is available. Similarly, 
prescribing is more easily adopted where the nurse has a clearly defined role or area of 
practice that is compatible with prescribing.
4.3.3 Framework of key determinants for the effective implementation and use of non­
medical prescribing
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The following is a framework in progress which has been developed on the basis of this 
body of research work and through reflecting on the above theoretical propositions. It is 
important to be clear about what is meant when talking about frameworks, as opposed to 
models and theory (Kitson et al. 2008, Ostrom 1999). According to Ostrom (1999), 
frameworks, theories and models can be viewed as operating along a continuum of 
increasing specificity. At the narrow end of the spectrum are models, which make 
precise assumptions about a specific situation. This is followed by theory, the role of 
which is to present clear and logically related sets of propositions to explain phenomena. 
At the broad end of the spectrum are conceptual frameworks, which identify a set of 
variables and the relationships among them that account for phenomena. Frameworks 
help to identify a list of variables or elements that need to be considered for an 
organisational analysis. Multiple models may be compatible with a theory, and several 
theories are compatible with one framework.
The framework presented here is a simple framework that identifies the key factors that 
need to be taken into consideration when evaluating the implementation of NMP. It is 
intended to provide useful guidance to commissioners and managers wishing to initiate 
or extend NMP, as well as to those researching NMP. The key determinants are set out 
across multiple levels; individual, interpersonal, organisational, inter-organisational and 
national. It borrows attributes of the ‘outer context’ (comprising of national and inter- 
organisational factors) from the conceptual model developed by Greenhalgh et a i (2004) 
based on literature on diffusion of innovations. It is a work in progress that requires 
development and refinement to test its validity in different contexts. In particular, further 
work is required to test its applicability to NMP in general (amongst different professions 
and within in a range of contexts).
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Framework of key determinants for the effective implementation and use of non-medical 
prescribing (NMP) _______________________________________________
Outer context
• Legislative governance and restrictions on what can be prescribed
• Political climate and acceptance of NMP
• National support and guidance for NMP
• Evaluation and research evidence for effectiveness of NMP
• Political incentives and health policy directives
Organisational procedures, policy and support
• Vision for the development of NMP set out within organisational strategy or policy, inclusion of 
NMP within commissioning cycle and workforce planning
• Extent of local formulary or other organisational policy restrictions on NMP and the level of 
equality between NMP and medical prescribing.
• Budgetary arrangements for NMP, cost of prescriptions
• Processes and approach to selecting appropriate candidates to undertake NMP qualification
• Adequacy of procedures for registration of NMPs, setting up agreement to prescribe, 
distribution of prescription pads and other requirements to prescribe.
• Clinical Governance procedures (including access to appropriate CPD, clinical supervision, 
audit of prescribing activity, incident reporting and disseminating essential information).
• Adequacy of mentoring and clinical supervision
• Capacity building within organisation to enable full use of NMP (numbers of NMPs within teams
and cover during absence)
• Existence of designated person/s to facilitate and represent NMP within organisation
• Extent of service re-design or re-configuration required to train or implement NMP (such as the 
availability of clinical mentors and the existence of nurse-led clinics)
Interpersonal aspects
• Preparation for and understanding of rules and limitations of NMP
• Cooperation of key stakeholders (such as doctors, pharmacists, nurses, patients)
• Established working relationships and mutual trust between NMP and clinicians
• Clarity of NMP role and agreement with stakeholders
• Peer support to enable learning, build confidence and combat isolation
• Advantages of supplementary prescribing within teams weighed against problems of 
implementing CMPs
Practicalities of prescribing
• Access to medical records
• Ability to continue care for individual patients
• Cost and ability to obtain medication
• Length of consultation or flexibility to alter length of consultation
• Access to advice from medical prescriber
• Clarity of definition of illness/condition and recommended/permitted treatment
Individual attributes
• Knowledge and extent of experience in clinical practice area
• Interpersonal and person-centred consultation skills
• Scope of practice, assessment, diagnostic and decision-making skills
• Attitude towards safety and prescribing within area of competence
• Confidence in ability to prescribe
• Motivation and expectations____________________________ ___________________________
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4.4 Dissemination and evidence of impact in the field of study
4.4.1 Feedback to participants
Following the analysis of findings from each study, endeavours were made to feedback 
the main findings to the study participants. For all studies, a written summary of findings 
(or copies of publications) were sent to nurses in the facilities where the research took 
place to disseminate to interested parties. Findings were also presented at meetings 
where nurse participants were present, such as diabetes or dermatology prescriber 
network meetings, a pain nurse forum and local conferences. As well as sharing the 
findings, these sessions were structured in order to gain feedback on the relevance and 
validity of the findings as a form of member validation. In each case, the feedback 
received was that the findings were a good representation of the experiences of the 
nurses (both by study participants and non-participants) and that there was a need to 
disseminate these important findings more widely.
4.4.2 Dissemination through presentation
The study findings have been widely disseminated at conferences and meetings at local, 
national and international events. These events attract a wide ranging audience, 
including nurses, doctors and other health professionals, service users, managers, 
policy makers, educators and researchers.
The following is a list of 18 presentations (14 oral and 4 posters) that I have personally 
made, sometimes co-presenting with my colleagues. The names given represent those 
of the presenters at that event. Numerous additional presentations of the supplementary 
work given by my colleagues Professor Molly Courtenay and Dr Nicola Carey are not 
included here.
93
a) Topic: Pain
• ‘What are nurses prescribing for pain?’ K Stenner and M Courtenay, 16th South 
Thames Acute Pain Group Conference, November 11th 2010, The Macdonald 
Frimley Hall Hotel, Camberley, Surrey, UK.
• ‘How nurse prescribing can benefit health service delivery: a qualitative study of 
nurse prescribing for patients in pain’. K Stenner, 28th May 2008, The Geneva 
Forum: Towards Global Access to Health, International Conference Centre 
Geneva, 25-28 May 2008.
• ‘The benefits of nurse prescribing according to nurses prescribing for patients for 
pain.’ K Stenner, symposium: ‘An exploration of stakeholder views of nurse 
prescribing’. Royal College of Nursing (RCN) International Nursing Research 
Conference, Liverpool. April 8th 2008.
• The impact of legislation on the prescription of controlled drugs by nurses.’ 
Poster presentation, K Stenner, 2008 RCN International Nursing Research 
Conference, Liverpool. April 8th-11th 2008
• ‘Nurses views on prescribing for patients in acute, chronic and palliative pain.’ K 
Stenner and M Courtenay, Portsmouth, Palliative Care conference, Spring 2007.
• ‘Nurse independent and nurse supplementary prescribing in acute and chronic 
pain.’ K Stenner and M Courtenay, presented at a national meeting of pain 
specialists held by NAPP pharmaceuticals, November 2007.
b) Topic: Dermatology
• The benefits of nurse prescribing for patients with dermatological conditions: 
Doctor views.’ M Courtenay & K Stenner, 18th annual meeting of the British 
Dermatological Nursing Group (BDNG), 1-4th July 2008, Liverpool ACC.
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•  ‘Nurse prescriber-patient consultations: a case study in dermatology.’ K Stenner, 
RCN International Nursing Research Conference, Cardiff, 24th-27th March 2009.
c) Topic: Diabetes
• ‘How patients with diabetes view nurse prescribing in primary care?’ K Stenner, 
RCN International Nursing Research Conference, 11-13th May, 2010, The Sage, 
Gateshead, UK. Part of symposium ‘Implementing nurse prescribing: the views 
and experiences of stakeholders’.
•  ‘Nurse prescribing: the views of patients with diabetes.’ K Stenner, Diabetes 
Nurse Prescriber Network, University of Surrey, 22nd February 2010.
• ‘How patients with diabetes view nurse prescribing?’ Poster presented by K 
Stenner at The University of Surrey, Faculty of Health and Medical Sciences, 
Festival of Research, 6th July 2010.
• ‘How patients with diabetes view nurse prescribing?’ Poster presented by K 
Stenner at 14th annual conference of the Federation of European nurses in 
Diabetes (FEND), 25-26 September 2009, Austria Centre Vienna.
• ‘How nurse prescribing effects the care patients receive: a case study in 
diabetes.’ K Stenner, 14th annual conference of the Federation of European 
nurses in Diabetes (FEND), 25-26 September 2009, Austria Centre Vienna.
• ‘Nurse prescribing for patients with diabetes: stakeholder views.’ K Stenner, RCN 
International Nursing Research Conference, Cardiff, 24th-27th March 2009.
• ‘Healthcare team views on the impact of nurse prescribing for patients with 
diabetes.’ Poster presentation by K Stenner at the Diabetes UK Annual 
Professional Conference 2009,11-13 March, SECC, Glasgow.
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• ‘Nurse prescribing in diabetes: implications for practice.’ Courtenay M. & Stenner 
K, National Prescribing Centre (NPC) 5th Non-medical prescribing conference,
10th February 2009, Regents Park Holiday Inn, London
d) Combined study papers
•  ‘Patients’ perceptions of nurse prescribing.’ K Stenner, Association for Nurse 
Prescribing (ANP) 12th annual conference, ‘Planning prescribing into 2012’, 
Holiday Inn, Birmingham City Centre, 28th September 2010.
• ‘Nurse prescribing: the impact on service delivery.’ M Courtenay and K Stenner, 
Association for Nurse Prescribing 11th Annual Conference, Reebok Centre,
Bolton 25th June 2009.
4.4.3 Evidence of impact of publications
a) Feedback
The feedback that I have received after presenting this work has been positive (see 
appendix 3 for example of formal feedback from conference presentation), and indicates 
that the work is timely and much needed in order to promote understanding of nurse 
prescribing. Dissemination helps to increase the visibility of NMP and raise its profile as 
a new area of practice. Anecdotal feedback from international attendees at conferences 
indicates that these findings provide both motivation and guidance to those considering 
the development of nurse prescribing outside of the UK. Feedback has also indicated 
that the findings have relevance to the development of NMP involving other health 
professionals, such as pharmacists. Through discussion with academic colleagues, I am 
aware that the work is regularly referenced within portfolios of evidence developed by 
postgraduate nursing students undertaking the NMP programme.
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b) Funding
Importantly, the publications have had a positive impact on the development of research 
work conducted within our research team. Each study has highlighted gaps in 
knowledge and identified areas for further work. This has helped to secure funding for a 
number of research projects over the past 5 years, for example, the success of project A 
helped secure funding for the survey in project B. As a result of the publications, the 
team was commissioned by two separate NHS health trusts to undertake evaluations of 
NMP within their trust. The work has now expanded to include all NMP and an 
exploration of organisational approaches to its development and governance. 
Theoretical ideas generated through this research continue to contribute to proposals for 
new research, for example, through the National Institute for Health Research Service 
Delivery and Organisation programme. The findings of this work have also informed a 
research proposal to measure the impact of nurse prescribing for patients with diabetes, 
the results of which will help refine the propositions and framework put forward in this 
thesis.
c) Citations
The Journal of Advanced Nursing (JAN) and the International Journal of Nursing Studies 
(UNS) are the top two international nursing research journals in terms of impact and 
reputation. While the Impact Factors for these journals may be lower than for medical 
journals in general, they receive the highest impact factors in the nursing field at 1.91 
(UNS) and 1.518 (JAN). These journals are recognised to have a wide international 
readership and articles are disseminated around the world. Six out of the 8 main papers 
submitted in this work are published in either the JAN or UNS.
97
It is difficult to gauge the impact of publications through citations when the publications 
have only been available for a couple of years, as is the case with the main papers. This 
is because it can take at least two years for research, which may potentially cite the 
work, to be conducted and then published. Despite this, there is evidence that the work 
is having an impact through citations index as shown in Table 4. Wiley Online Library 
recorded the most citations at a total of 15. Given the limited time frame, this provides 
confirmation that the research is having an impact in the research and practice 
communities.
Table 4. Number of citations for main publications recorded on 09/02/2011
Paper Wiley online library Web of Science Scopus
P1 5 4 6
P2 7 3 4
P5 1 3 3
P6 2 0 1
In addition to those citations listed in Table 4, I am aware of three further publications 
that have cited work:
• P5 is cited in an evaluation of non-medical prescribing in Ireland (Drennan 2009)
•  P2 is cited in a literature review of nurse prescribing (O'Connell 2009)
•  P1 and P5 are cited in a report produced by the National Prescribing Centre
(NPC) to guide commissioners in developing non-medical prescribing (National 
Prescribing Centre 2010).
Papers 4 and 8 were not yet available in print at the time of writing, however, the 
following quotations are examples of comments made by anonymous reviewers of paper 
4 when submitted for publication:
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‘An interesting survey that shows a robust attempt to access the study population 
and findings that will certainly be of interest to many readers (not least in the UK 
but also internationally)’.
‘i believe this to be a timely and quality paper that focuses and informs an 
important and growing extension of nurse practice. I enjoyed the paper and was 
informed by its contents. I embrace the obvious scholarship of the authors 
approach and presentation. This text, with its clear content, context and 
presentation is easily understandable to an international reader. This paper will 
serve the journal well.’
No information was available on papers 3 and 7 which were published in ‘Nurse
Prescribing’, which does not have an impact factor. There is little incentive to publish in
journals without a recognised impact factor, however less prestigious but widely read
journals such as ‘nurse prescribing’ have a fast turnaround and can increase the
readership and reach of the work.
d) Policy and guidance 
Publications 1 and 5 have been used to inform guidance for commissioners on the 
development of NMP (National Prescribing Centre (NPC) 2010). The work has also been 
used to inform the forthcoming NMP lead handbook to be published by the NPC. This is 
an indication of the value and relevance of this work to the NHS.
The findings of Paper 3 had direct relevance to practice and to the public consultation 
that was underway at the time on nurse and pharmacist independent prescribing of 
controlled drugs (Home Office 2007). Immediate attention was paid to securing rapid 
publication so that the findings could contribute evidence for consideration during this 
public consultation in 2007. Just as previous nurse prescribing formularies were found to 
restrict nurses in their ability to improve care (Ball 2009), the controlled drug legislation 
was found to cause confusion as to what could be legally prescribed and prevented
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optimum care for patients. In addition to the publications from project A (P1, P2, P3), 
findings and recommendations were disseminated by Professor Molly Courtenay in her 
capacity as advisor for the Royal College of Nursing (RCN) and later the Association for 
Nurse Prescribing (ANP). It is not possible to tell if the paper had any direct influence, 
but the outcome of the consultation was a decision to revise the legislation and enable 
nurses to prescribe a wider range of controlled drugs. Unfortunately, some three years 
later, the legislation remains unchanged. It is now hoped that the findings of P4, which 
demonstrate the continued need to revise the controlled drug legislation, will provide 
impetus for change. Professor Courtenay, in her capacity as chair of the Nurse 
Prescribers’ Advisory Group (NPAG), was asked by the DH to send findings of P4 to the 
Home Office with the hope that it would help to speed up the process of change.
4.5 Recommendations for future research
In order to be of greater value, the propositions and framework developed as a result of 
this work require refinement and testing in different contexts. There are, for example, 
indications that the barriers and facilitators to nurse prescribing in mental health may 
differ in emphasis to those reported in this work (Bradley et al. 2008, Jones et al. 2007, 
McCann & Clark 2008, Nolan & Bradley 2007, Snowden 2008). Issues encountered 
when developing non-medical prescribing amongst other health professionals may differ 
to those facing nurses. It is also noted that the views of managers, educators, health 
service commissioners and policy makers were not included as stakeholders in these 
publications and could provide valuable alternative perspectives. Furthermore, the type 
of data upon which the propositions are based is mainly self-report data and could 
therefore be strengthened by evaluation based on other forms of measurable outcome 
data (such as the use of validated scales or health outcome data).
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Further work is required to clarify the extent to which clinical governance procedures and 
policies for selection of candidates to undertake the non-medical prescribing course are 
being implemented within organisations. Work is currently underway at the University of 
Surrey on the role of the NMP lead within two NHS organisations and their views on the 
factors influencing the development and use of NMP. These projects will provide 
valuable additional information to this framework from a pan-organisational perspective.
The impact of nurse prescribing on clinical practice and the level of decision-making that 
nurses engage in is an area that merits further exploration.
If and when legislation on nurse independent prescribing of controlled drugs is amended, 
a follow-up study to that reported in P4 is recommended to measure any change in the 
pain nurse role or prescribing activity. Furthermore, nurse prescribing within chronic pain 
clinics, palliative care, general practice and community settings remains unexplored.
Benefits were reported by stakeholders in relation to improved use of evidence-based 
medicine by nurse prescribers. Further research is required to identify whether there is 
any measurable impact of nurse prescribing on the use of evidence-based practice in 
relation to pain management, and other areas of practice. If nurse prescribing can be 
viewed as an initiative to improve the uptake of evidence-based practice, there is scope 
to evaluate this within the Promoting Action on Research Implementation in Health 
Services (PARiHS) framework (Kitson et al. 2008).
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5. C onclusions
This introductory statement has discussed the key areas in which this work has 
contributed to the evaluation of nurse prescribing in England within the treatment areas 
of pain, dermatology and diabetes. Together the publications form a comprehensive 
evaluation of nurse independent and nurse supplementary prescribing from the 
viewpoint of key stakeholders such as nurses, patients and doctors.
Nurse prescribing was positively received by research participants and a range of 
benefits reported. Each of the treatment areas had been the focus of a national drive to 
improve service provision and nurse prescribing was reported to facilitate these 
improvements. The publications have made the nursing contribution to prescribing 
medicines more visible and provided important benchmark information about nurse 
prescribing for patients in pain.
A major contribution is made to understanding the mechanisms and processes through 
which benefits arise from nurse prescribing and the contextual factors that determine 
them. A theory is proposed that describes a set of causal relationships between factors 
that influence the outcomes of nurse prescribing. The combination of specialist 
knowledge and experience, patient-centred communication skill, and the autonomy to 
prescribe, is predicted to result in improvements beyond that of normal care.
The work has expanded understanding about the impact of prescribing on the role of the 
nurse and opened debate about the level of prescribing autonomy and decision-making 
that is acceptable to stakeholders. It has demonstrated the inter-active process through
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which nurses negotiate changes to professional boundaries and illustrates the evolving 
nature of advancing nurse roles.
The act of compiling this introductory statement provided an opportunity to use the 
principles of realistic evaluation to generate a set of propositions about what determines 
the impact of nurse prescribing and what is required to successfully implement it. The 
barriers and facilitators identified in the publications have been used to develop a 
framework to guide the development and implementation of non-medical prescribing. 
The framework identifies the key factors that influence the implementation at the level of 
the individual, team, organisation and wider society. Further work is required to refine 
this framework and test its applicability to non-medical prescribing in general.
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